FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions icon

4.4.1.501 ValueSet http://hl7.org/fhir/ValueSet/report-codes

Orders and Observations icon Work Group Maturity Level: 0Informative Use Context: Country: World
Official URL: http://hl7.org/fhir/ValueSet/report-codes Version: 6.0.0-cibuild
draft as of 2024-05-14 Computable Name: LOINCDiagnosticReportCodes
Flags: OID: 2.16.840.1.113883.4.642.3.233

This value set is used in the following places:

4.4.1.501.1 Definition

This value set includes LOINC codes that relate to Diagnostic Observations.

4.4.1.501.2 Content Logical Definition

 

4.4.1.501.3 Expansion

This expansion generated 14 May 2024

Expansion based on Loinc v2.77

This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown

CodeSystemDisplay
  100000-9 iconhttp://loinc.orgHealth informatics pioneer and the father of LOINC
  100001-7 iconhttp://loinc.orgHealth informatics pioneer and cofounder of LOINC
  100002-5 iconhttp://loinc.orgSpecimen care is maintained
  100003-3 iconhttp://loinc.orgTeam communication is maintained throughout care
  100004-1 iconhttp://loinc.orgDemonstrates knowledge of the expected psychosocial responses to the procedure
  100005-8 iconhttp://loinc.orgDemonstrates knowledge of nutritional management related to the procedure
  100006-6 iconhttp://loinc.orgDemonstrates knowledge of medication management
  100007-4 iconhttp://loinc.orgDemonstrates knowledge of pain management
  10000-8 iconhttp://loinc.orgR wave duration in lead AVR
  100008-2 iconhttp://loinc.orgDemonstrates knowledge of wound management
  100009-0 iconhttp://loinc.orgDemonstrates knowledge of the procedure and expected results
  100010-8 iconhttp://loinc.orgNo injury related to procedure equipment, medical supplies, or instrumentation
  100011-6 iconhttp://loinc.orgNo injury related to an electrical source
  100012-4 iconhttp://loinc.orgParticipates in decisions affecting the patient's plan of care
  100013-2 iconhttp://loinc.orgParticipates in the discharge process
  100014-0 iconhttp://loinc.orgPsychosocial health is maintained at or improved from baseline
  100015-7 iconhttp://loinc.orgNo injury related to positioning due to care or procedure
  10001-6 iconhttp://loinc.orgR wave duration in lead I
  100016-5 iconhttp://loinc.orgNo injury related to a laser source
  100017-3 iconhttp://loinc.orgPerioperative nursing data set outcomes panel [PNDS]
  100018-1 iconhttp://loinc.orgHospice care Note
  100019-9 iconhttp://loinc.orgALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100020-7 iconhttp://loinc.orgGNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100021-5 iconhttp://loinc.orgGNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100022-3 iconhttp://loinc.orgIDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100023-1 iconhttp://loinc.orgIDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  10002-4 iconhttp://loinc.orgR wave duration in lead II
  100024-9 iconhttp://loinc.orgSETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100025-6 iconhttp://loinc.orgSRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100026-4 iconhttp://loinc.orgMET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100027-2 iconhttp://loinc.orgSMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100028-0 iconhttp://loinc.orgFBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100029-8 iconhttp://loinc.orgCancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method
  100030-6 iconhttp://loinc.orgAxis I: Temporal aspects score [Mainz Pain Staging System]
  100031-4 iconhttp://loinc.orgAxis II: Spatial aspects score [Mainz Pain Staging System]
  10003-2 iconhttp://loinc.orgR wave duration in lead III
  100032-2 iconhttp://loinc.orgAxis III: Drug taking behavior score [Mainz Pain Staging System]
  100033-0 iconhttp://loinc.orgAxis IV: Utilization of the health care system score [Mainz Pain Staging System]
  100034-8 iconhttp://loinc.orgProvider of automated external defibrillator use
  100035-5 iconhttp://loinc.orgExam finding location of Chest
  100036-3 iconhttp://loinc.orgExam finding location of Lung
  100037-1 iconhttp://loinc.orgPatient contact disposition EMS unit
  100038-9 iconhttp://loinc.orgPatient evaluation disposition EMS unit
  100039-7 iconhttp://loinc.orgCrew disposition for patient care EMS unit
  10004-0 iconhttp://loinc.orgR wave duration in lead V1
  100040-5 iconhttp://loinc.orgPatient transport disposition EMS unit
  100041-3 iconhttp://loinc.orgAminoglycoside [Susceptibility]
  100042-1 iconhttp://loinc.orgAtovaquone [Susceptibility]
  100043-9 iconhttp://loinc.orgAzithromycin+Ethambutol [Susceptibility]
  100044-7 iconhttp://loinc.orgCefcapene [Susceptibility]
  100045-4 iconhttp://loinc.orgCefozopran [Susceptibility]
  100046-2 iconhttp://loinc.orgCefquinome [Susceptibility]
  100047-0 iconhttp://loinc.orgCefteram [Susceptibility]
  100048-8 iconhttp://loinc.orgClarithromycin+Ethambutol [Susceptibility]
  100049-6 iconhttp://loinc.orgEravacycline [Susceptibility]
  100050-4 iconhttp://loinc.orgErythromycin+Ethambutol [Susceptibility]
  100051-2 iconhttp://loinc.orgEthambutol+rifAMPin [Susceptibility]
  100052-0 iconhttp://loinc.orgFlomoxef [Susceptibility]
  100053-8 iconhttp://loinc.orgFluoroquinolone [Susceptibility]
  100054-6 iconhttp://loinc.orgGamithromycin [Susceptibility]
  100055-3 iconhttp://loinc.orgOptochin [Susceptibility]
  100056-1 iconhttp://loinc.orgPanipenem [Susceptibility]
  10005-7 iconhttp://loinc.orgR wave duration in lead V2
  100057-9 iconhttp://loinc.orgProthionamide [Susceptibility]
  100058-7 iconhttp://loinc.orgPrulifloxacin [Susceptibility]
  100059-5 iconhttp://loinc.orgRifapentine [Susceptibility]
  100060-3 iconhttp://loinc.orgTildipirosin [Susceptibility]
  100061-1 iconhttp://loinc.orgTosufloxacin [Susceptibility]
  100062-9 iconhttp://loinc.orgStandard Dermatology Outcome Measures panel
  100063-7 iconhttp://loinc.orgPrimary skin concern
  100064-5 iconhttp://loinc.orgItch severity Reporting Period - Reported
  10006-5 iconhttp://loinc.orgR wave duration in lead V3
  100065-2 iconhttp://loinc.orgSatisfied with treatment
  100066-0 iconhttp://loinc.orgSpecular microscopy panel
  100067-8 iconhttp://loinc.orgEye Image magnification
  100068-6 iconhttp://loinc.orgRight eye Fixation point [Angle]
  100069-4 iconhttp://loinc.orgLeft eye Fixation point [Angle]
  100070-2 iconhttp://loinc.orgRight cornea Cell density
  100071-0 iconhttp://loinc.orgLeft cornea Cell density
  100072-8 iconhttp://loinc.orgRight cornea Coefficient of variation
  10007-3 iconhttp://loinc.orgR wave duration in lead V4
  100073-6 iconhttp://loinc.orgLeft cornea Coefficient of variation
  100074-4 iconhttp://loinc.orgRight cornea Hexagonality
  100075-1 iconhttp://loinc.orgLeft cornea Hexagonality
  100076-9 iconhttp://loinc.orgRight cornea Endothelial cells counted
  100077-7 iconhttp://loinc.orgLeft cornea Endothelial cells counted
  100078-5 iconhttp://loinc.orgRight cornea Endothelial cell area.min
  100079-3 iconhttp://loinc.orgLeft cornea Endothelial cell area.min
  100080-1 iconhttp://loinc.orgRight cornea Endothelial cell area.max
  10008-1 iconhttp://loinc.orgR wave duration in lead V5
  100081-9 iconhttp://loinc.orgLeft cornea Endothelial cell area.max
  100082-7 iconhttp://loinc.orgRight cornea Endothelial cell area.mean
  100083-5 iconhttp://loinc.orgLeft cornea Endothelial cell area.mean
  100084-3 iconhttp://loinc.orgRight cornea Cell area.standard deviation
  100085-0 iconhttp://loinc.orgLeft cornea Cell area.standard deviation
  100086-8 iconhttp://loinc.orgRight cornea Type of Analysis method by Specular microscopy
  100087-6 iconhttp://loinc.orgToxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot
  100088-4 iconhttp://loinc.orgTaenia solium larva Ab bands panel - Serum by Immunoblot
  100089-2 iconhttp://loinc.orgTaenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot
  1000-9 iconhttp://loinc.orgDBG Ab [Presence] in Serum or Plasma from Blood product unit
  100090-0 iconhttp://loinc.orgTaenia solium larva 45kD Ab [Presence] in Serum by Immunoblot
  100091-8 iconhttp://loinc.orgTrypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay
  100092-6 iconhttp://loinc.orgTrypanosoma cruzi Ab bands panel - Serum by Immunoblot
  100093-4 iconhttp://loinc.orgTrypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot
  100094-2 iconhttp://loinc.orgTrypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot
  100095-9 iconhttp://loinc.orgTrypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot
  100096-7 iconhttp://loinc.orgTrypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot
  100097-5 iconhttp://loinc.orgTrypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot
  100098-3 iconhttp://loinc.orgTrypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot
  10009-9 iconhttp://loinc.orgR wave duration in lead V6
  100099-1 iconhttp://loinc.orgTrypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot
  100100-7 iconhttp://loinc.orgFasciola sp IgG Ab [Presence] in Serum by Immunoassay
  100101-5 iconhttp://loinc.orgFasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot
  100102-3 iconhttp://loinc.orgFasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot
  100103-1 iconhttp://loinc.orgFasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot
  100104-9 iconhttp://loinc.orgFasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot
  100105-6 iconhttp://loinc.orgFilaria IgG and IgM panel - Serum
  100106-4 iconhttp://loinc.orgFilaria IgG Ab [Presence] in Serum by Immunoassay
  10010-7 iconhttp://loinc.orgR' wave amplitude in lead AVF
  100107-2 iconhttp://loinc.orgLeishmania sp IgG Ab [Presence] in Serum by Immunoassay
  100108-0 iconhttp://loinc.orgLeishmania sp IgG Ab [Units/volume] in Serum by Immunoassay
  100109-8 iconhttp://loinc.orgLeishmania sp Ab bands panel - Serum by Immunoblot
  100110-6 iconhttp://loinc.orgLeishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot
  100111-4 iconhttp://loinc.orgLeishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot
  100112-2 iconhttp://loinc.orgFasciola sp Ab bands panel - Serum by Immunoblot
  100113-0 iconhttp://loinc.orgHelicobacter pylori Ab panel - Serum
  100114-8 iconhttp://loinc.orgToxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot
  10011-5 iconhttp://loinc.orgR' wave amplitude in lead AVL
  100115-5 iconhttp://loinc.orgToxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot
  100116-3 iconhttp://loinc.orgToxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot
  100117-1 iconhttp://loinc.orgToxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot
  100118-9 iconhttp://loinc.orgToxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot
  100119-7 iconhttp://loinc.orgToxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot
  100120-5 iconhttp://loinc.orgChlamydia trachomatis Ab panel - Serum
  100121-3 iconhttp://loinc.orgChlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay
  100122-1 iconhttp://loinc.orgChlamydophila pneumoniae Ab panel - Serum
  10012-3 iconhttp://loinc.orgR' wave amplitude in lead AVR
  100123-9 iconhttp://loinc.orgChlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay
  100124-7 iconhttp://loinc.orgChlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay
  100125-4 iconhttp://loinc.orgChlamydophila psittaci Ab panel - Serum
  100126-2 iconhttp://loinc.orgBordetella pertussis Ab.IgG panel - Serum
  100127-0 iconhttp://loinc.orgCampylobacter sp Ab panel - Serum
  100128-8 iconhttp://loinc.orgCryptococcus sp Ag panel - Serum
  100129-6 iconhttp://loinc.orgSchistosoma sp Ab [Titer] in Serum by Hemagglutination
  100130-4 iconhttp://loinc.orgSchistosoma mansoni Ab [Presence] in Serum by Immunoblot
  10013-1 iconhttp://loinc.orgR' wave amplitude in lead I
  100131-2 iconhttp://loinc.orgSchistosoma sp 8kD Ab [Presence] in Serum by Immunoblot
  100132-0 iconhttp://loinc.orgSchistosoma sp 9kD Ab [Presence] in Serum by Immunoblot
  100133-8 iconhttp://loinc.orgSchistosoma sp 10kD Ab [Presence] in Serum by Immunoblot
  100134-6 iconhttp://loinc.orgSchistosoma sp 11kD Ab [Presence] in Serum by Immunoblot
  100135-3 iconhttp://loinc.orgSchistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot
  100136-1 iconhttp://loinc.orgSchistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot
  100137-9 iconhttp://loinc.orgSchistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot
  100138-7 iconhttp://loinc.orgSchistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot
  100139-5 iconhttp://loinc.orgSchistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot
  100140-3 iconhttp://loinc.orgSchistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot
  100141-1 iconhttp://loinc.orgSchistosoma sp 65kD Ab [Presence] in Serum by Immunoblot
  100142-9 iconhttp://loinc.orgSchistosoma sp 70kD Ab [Presence] in Serum by Immunoblot
  100143-7 iconhttp://loinc.orgSchistosoma sp 80kD Ab [Presence] in Serum by Immunoblot
  100144-5 iconhttp://loinc.orgSchistosoma sp 95kD Ab [Presence] in Serum by Immunoblot
  100145-2 iconhttp://loinc.orgSchistosoma sp 110kD Ab [Presence] in Serum by Immunoblot
  100146-0 iconhttp://loinc.orgSchistosoma sp 120kD Ab [Presence] in Serum by Immunoblot
  100147-8 iconhttp://loinc.orgToxoplasma gondii Ab bands panel - Serum by Immunoblot
  100148-6 iconhttp://loinc.orgSchistosoma sp Ab bands panel - Serum by Immunoblot
  10014-9 iconhttp://loinc.orgR' wave amplitude in lead II
  100149-4 iconhttp://loinc.org6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma
  100150-2 iconhttp://loinc.org6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma
  100151-0 iconhttp://loinc.org6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma
  100152-8 iconhttp://loinc.org6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
  100153-6 iconhttp://loinc.org6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
  100154-4 iconhttp://loinc.orgSpecimen collection supervision level
  100155-1 iconhttp://loinc.orgLeft cornea Type of Analysis method by Specular microscopy
  10015-6 iconhttp://loinc.orgR' wave amplitude in lead III
  100156-9 iconhttp://loinc.orgSARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
  100157-7 iconhttp://loinc.orgSARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
  100158-5 iconhttp://loinc.orgMicroalbumin [Mass/volume] in Urine collected for unspecified duration
  100159-3 iconhttp://loinc.orgKnee Society Score pre-op panel [Knee Society Score]
  100160-1 iconhttp://loinc.orgKnee replacement
  100161-9 iconhttp://loinc.orgCharnley Functional Classification
  100162-7 iconhttp://loinc.orgKnee alignment W standing X-ray measured
  100163-5 iconhttp://loinc.orgKnee medial AndOr lateral instability W full extension
  10016-4 iconhttp://loinc.orgR' wave amplitude in lead V1
  100164-3 iconhttp://loinc.orgKnee AP instability W 90 degree flexion
  100165-0 iconhttp://loinc.orgKnee range of motion
  100166-8 iconhttp://loinc.orgFlexion contracture range of Knee
  100167-6 iconhttp://loinc.orgExtensor lag range of Knee
  100168-4 iconhttp://loinc.orgKnee pain severity with level walking
  100169-2 iconhttp://loinc.orgKnee pain severity with stairs or inclines
  1001-7 iconhttp://loinc.orgDBG Ab [Presence] in Serum or Plasma from Donor
  100170-0 iconhttp://loinc.orgKnee feels normal
  100171-8 iconhttp://loinc.orgSatisfaction with level of knee pain while sitting
  10017-2 iconhttp://loinc.orgR' wave amplitude in lead V2
  100172-6 iconhttp://loinc.orgSatisfaction with level of knee pain while lying in bed
  100173-4 iconhttp://loinc.orgSatisfaction with knee function while getting out of bed
  100174-2 iconhttp://loinc.orgSatisfaction with knee function while performing light household duties
  100175-9 iconhttp://loinc.orgSatisfaction with knee function while performing recreational activities
  100176-7 iconhttp://loinc.orgExpect surgery to relieve pain
  100177-5 iconhttp://loinc.orgExpect surgery will improve ability to perform activities of daily living
  100178-3 iconhttp://loinc.orgExpect surgery will improve ability to perform leisure, recreational, or sports activities
  100179-1 iconhttp://loinc.orgWalk without assistive mobility devices
  10018-0 iconhttp://loinc.orgR' wave amplitude in lead V3
  100180-9 iconhttp://loinc.orgAssistive mobility devices used
  100181-7 iconhttp://loinc.orgAssistive mobility devices used due to health condition
  100182-5 iconhttp://loinc.orgDuration of standing before sitting due to knee discomfort
  100183-3 iconhttp://loinc.orgDuration of walking before stopping due to knee discomfort
  100184-1 iconhttp://loinc.orgHow bothersome is knee when walking on an uneven surface
  100185-8 iconhttp://loinc.orgHow bothersome is knee when turning or pivoting leg
  100186-6 iconhttp://loinc.orgHow bothersome is knee when climbing up or down a flight of stairs
  100187-4 iconhttp://loinc.orgHow bothersome is knee when getting up from a low seat without armrests
  100188-2 iconhttp://loinc.orgHow bothersome is knee when getting into or out of a car
  100189-0 iconhttp://loinc.orgHow bothersome is knee when moving laterally
  100190-8 iconhttp://loinc.orgHow bothersome is knee when climbing a ladder or step stool
  100191-6 iconhttp://loinc.orgHow bothersome is knee when carrying a bag for one block
  100192-4 iconhttp://loinc.orgHow bothersome is knee when squatting
  100193-2 iconhttp://loinc.orgHow bothersome is knee when kneeling
  100194-0 iconhttp://loinc.orgHow bothersome is knee when running
  100195-7 iconhttp://loinc.orgPain severity--during activity
  100196-5 iconhttp://loinc.orgPre-op total score [Knee Society Score]
  100197-3 iconhttp://loinc.orgExercise activity and pain severity panel
  10019-8 iconhttp://loinc.orgR' wave amplitude in lead V4
  100198-1 iconhttp://loinc.orgPre-op objective knee indicators score [Knee Society Score]
  100199-9 iconhttp://loinc.orgPre-op symptoms score [Knee Society Score]
  100200-5 iconhttp://loinc.orgPre-op patient expectations score [Knee Society Score]
  100201-3 iconhttp://loinc.orgPre-op functional activities score [Knee Society Score]
  100202-1 iconhttp://loinc.orgPre-op discretionary knee activities score [Knee Society Score]
  100203-9 iconhttp://loinc.orgKnee Society Score post-op panel [Knee Society Score]
  100204-7 iconhttp://loinc.orgAccuracy of pre-surgery expectations of pain relief
  100205-4 iconhttp://loinc.orgAccuracy of pre-surgery expectations to perform activities of daily living
  10020-6 iconhttp://loinc.orgR' wave amplitude in lead V5
  100206-2 iconhttp://loinc.orgAccuracy of pre-surgery expectations to perform leisure, recreational, or sports activities
  100207-0 iconhttp://loinc.orgPost-op total score [Knee Society Score]
  100208-8 iconhttp://loinc.orgPost-op objective knee indicators score [Knee Society Score]
  100209-6 iconhttp://loinc.orgPost-op symptoms score [Knee Society Score]
  100210-4 iconhttp://loinc.orgPost-op patient expectations score [Knee Society Score]
  100211-2 iconhttp://loinc.orgPost-op functional activities score [Knee Society Score]
  100212-0 iconhttp://loinc.orgPost-op discretionary knee activities score [Knee Society Score]
  100213-8 iconhttp://loinc.orgProstate cancer multigene analysis in Blood or Tissue by Molecular genetics method
  10021-4 iconhttp://loinc.orgR' wave amplitude in lead V6
  100214-6 iconhttp://loinc.orgDental model prior authorization Document
  100215-3 iconhttp://loinc.orgEpisode of care medical records Document Transplant surgery
  100216-1 iconhttp://loinc.orgSurgical synoptic report
  100217-9 iconhttp://loinc.orgSynoptic report Narrative Surgical oncology
  100218-7 iconhttp://loinc.orgSurgical oncology of colon cancer synoptic report
  100219-5 iconhttp://loinc.orgSurgical oncology of melanoma cancer synoptic report
  100220-3 iconhttp://loinc.orgSurgical oncology of breast cancer synoptic report
  100221-1 iconhttp://loinc.orgSurgical oncology of thyroid cancer synoptic report
  10022-2 iconhttp://loinc.orgR' wave duration in lead AVF
  100222-9 iconhttp://loinc.orgSurgical oncology of pancreas cancer synoptic report
  100223-7 iconhttp://loinc.orgPhysical findings of Retina Narrative
  100224-5 iconhttp://loinc.orgCardiac left ventricular segmental wall motion by echo panel
  100225-2 iconhttp://loinc.orgBone density quantitative ultrasound study
  100226-0 iconhttp://loinc.orgSmall bowel capsule endoscopy study Document
  100227-8 iconhttp://loinc.orgColon capsule endoscopy study Document
  100228-6 iconhttp://loinc.orgUpper gastrointestinal capsule endoscopy study Document
  100229-4 iconhttp://loinc.orgEndoscopic ultrasound study Document
  10023-0 iconhttp://loinc.orgR' wave duration in lead AVL
  100230-2 iconhttp://loinc.orgRoutine prenatal assessment panel
  100231-0 iconhttp://loinc.orgEndobronchial ultrasound study
  100232-8 iconhttp://loinc.orgImpacts of Events Scale-Revised panel
  100233-6 iconhttp://loinc.orgReminders brought back feelings about adverse event
  100234-4 iconhttp://loinc.orgTrouble staying asleep
  100235-1 iconhttp://loinc.orgOther things triggered persistent thoughts about adverse event
  100236-9 iconhttp://loinc.orgFelt irritable AndOr angry
  100237-7 iconhttp://loinc.orgAvoided getting upset when unintentionally thought about adverse event
  100238-5 iconhttp://loinc.orgThought about adverse event unintentionally
  100239-3 iconhttp://loinc.orgFelt as if adverse event did not happen
  100240-1 iconhttp://loinc.orgAvoided reminders of adverse event
  100241-9 iconhttp://loinc.orgExperienced mental images of adverse event
  100242-7 iconhttp://loinc.orgEasily startled
  100243-5 iconhttp://loinc.orgTried to not think of adverse event
  100244-3 iconhttp://loinc.orgAware of feelings about adverse event, but did not address them
  100245-0 iconhttp://loinc.orgFeelings about adverse event were numb
  100246-8 iconhttp://loinc.orgActed or felt the same as during adverse event
  100247-6 iconhttp://loinc.orgTrouble falling asleep
  10024-8 iconhttp://loinc.orgR' wave duration in lead AVR
  100248-4 iconhttp://loinc.orgWaves of strong feelings about adverse event
  100249-2 iconhttp://loinc.orgTried to remove adverse event from memory
  1002-5 iconhttp://loinc.orgDBG Ab [Presence] in Serum or Plasma
  100250-0 iconhttp://loinc.orgTrouble concentrating
  100251-8 iconhttp://loinc.orgReminders of adverse event caused physical reactions
  100252-6 iconhttp://loinc.orgHad dreams about adverse event
  100253-4 iconhttp://loinc.orgFelt watchful and on-guard
  100254-2 iconhttp://loinc.orgTried not to talk about adverse event
  10025-5 iconhttp://loinc.orgR' wave duration in lead I
  100255-9 iconhttp://loinc.orgTotal score [Impact of Event Scale-Revised]
  100256-7 iconhttp://loinc.orgFallen in last 6 months
  100257-5 iconhttp://loinc.orgFeel unsteady when standing or walking
  100258-3 iconhttp://loinc.orgHistory of fall related injury
  100259-1 iconhttp://loinc.orgAware of tactile sensations
  100260-9 iconhttp://loinc.orgEasy to describe thoughts AndOr feelings
  100261-7 iconhttp://loinc.orgCritical of own thoughts AndOr feelings
  100262-5 iconhttp://loinc.orgAble to notice distressing thoughts AndOr feelings without having to react
  10026-3 iconhttp://loinc.orgR' wave duration in lead II
  100263-3 iconhttp://loinc.orgEasily distracted
  100264-1 iconhttp://loinc.orgAble to notice thoughts AndOr feelings without being overwhelmed
  100265-8 iconhttp://loinc.orgAware of dietary intake impact on self
  100266-6 iconhttp://loinc.orgDifficult to describe thoughts AndOr feelings
  100267-4 iconhttp://loinc.orgAware of auditory stimuli
  100268-2 iconhttp://loinc.orgAble to avoid immediate reaction in difficult situations
  100269-0 iconhttp://loinc.orgDo things without paying attention
  100270-8 iconhttp://loinc.orgRecover quickly from distressing thoughts AndOr images
  10027-1 iconhttp://loinc.orgR' wave duration in lead III
  100271-6 iconhttp://loinc.orgAware of olfactory stimuli
  100272-4 iconhttp://loinc.orgAware of visual stimuli
  100273-2 iconhttp://loinc.orgAware of emotions affect on thoughts AndOr behavior
  100274-0 iconhttp://loinc.orgObserving score [FFMQ]
  100275-7 iconhttp://loinc.orgDescribing score [FFMQ]
  100276-5 iconhttp://loinc.orgActing with awareness score [FFMQ]
  100277-3 iconhttp://loinc.orgNonjudging score [FFMQ]
  100278-1 iconhttp://loinc.orgNonreactivity score [FFMQ]
  100279-9 iconhttp://loinc.orgTotal score [FFMQ]
  100280-7 iconhttp://loinc.orgFive Facet Mindfulness Questionnaire panel [FFMQ]
  100281-5 iconhttp://loinc.orgD Ab [Units/volume] in Serum or Plasma
  100282-3 iconhttp://loinc.orgVaccine exemption certificate
  100283-1 iconhttp://loinc.orgHarris Hip Score panel [Harris Hip Score]
  100284-9 iconhttp://loinc.orgWalking - functional ability
  100285-6 iconhttp://loinc.orgComfortable seated position
  100286-4 iconhttp://loinc.orgAble to board public transportation
  100287-2 iconhttp://loinc.orgPut on shoes and socks
  100288-0 iconhttp://loinc.orgAbsence of deformity score [Harris Hip Score]
  10028-9 iconhttp://loinc.orgR' wave duration in lead V1
  100289-8 iconhttp://loinc.orgAbsence of hip deformity measurements
  100290-6 iconhttp://loinc.orgRange of motion score [Harris Hip Score]
  100291-4 iconhttp://loinc.orgTotal score [Harris Hip Score]
  100292-2 iconhttp://loinc.orgPre-op patient satisfaction score [Knee Society Score]
  100293-0 iconhttp://loinc.orgHip Flexion range of motion
  100294-8 iconhttp://loinc.orgHip Abduction range of motion
  100295-5 iconhttp://loinc.orgHip Adduction range of motion
  100296-3 iconhttp://loinc.orgHip External rotation range of motion
  10029-7 iconhttp://loinc.orgR' wave duration in lead V2
  100297-1 iconhttp://loinc.orgHip Internal rotation range of motion
  100298-9 iconhttp://loinc.orgRepetition count
  100299-7 iconhttp://loinc.orgPost-op patient satisfaction score [Knee Society Score]
  100300-3 iconhttp://loinc.orgEnd time Unspecified body region
  100301-1 iconhttp://loinc.orgStart time Unspecified body region
  100302-9 iconhttp://loinc.orgTime period start and end panel Unspecified body region
  100303-7 iconhttp://loinc.orgCondition certainty of presence
  100304-5 iconhttp://loinc.orgFlights climbed [#] Reporting Period
  10030-5 iconhttp://loinc.orgR' wave duration in lead V3
  100305-2 iconhttp://loinc.orgIDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
  100306-0 iconhttp://loinc.orgIDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
  100307-8 iconhttp://loinc.orgBehavioral screening elder mistreatment
  100308-6 iconhttp://loinc.orgNeed help getting to essential places
  100309-4 iconhttp://loinc.orgActivity support person
  100310-2 iconhttp://loinc.orgReliability of support person
  100311-0 iconhttp://loinc.orgNeed help to make sure there is enough food, medicines or any other things needed in house
  100312-8 iconhttp://loinc.orgPerson or persons that makes sure there is enough food, medicines or any other things needed in house
  10031-3 iconhttp://loinc.orgR' wave duration in lead V4
  100313-6 iconhttp://loinc.orgNeed help with household things such as cook meals, help feed, or provide correct medicines each day
  100314-4 iconhttp://loinc.orgNeed help with house cleaning or yard work
  100315-1 iconhttp://loinc.orgNeed help getting out of bed, showered, or dressed
  100316-9 iconhttp://loinc.orgNeed help to make sure bills get paid
  100317-7 iconhttp://loinc.orgRelationship of usual support person for daily activities
  100318-5 iconhttp://loinc.orgHave help with finances AndOr financial decisions
  100319-3 iconhttp://loinc.orgRelationship of financial support person
  100320-1 iconhttp://loinc.orgFinancial support person usually asks for permission before making decisions
  10032-1 iconhttp://loinc.orgR' wave duration in lead V5
  100321-9 iconhttp://loinc.orgFinancial support person usually makes good decisions about finances
  100322-7 iconhttp://loinc.orgHave access to paperwork for financial decisions made
  100323-5 iconhttp://loinc.orgFinancial support person forged signature
  100324-3 iconhttp://loinc.orgCoercion of financial support person for signing a document in order to get money or possessions
  100325-0 iconhttp://loinc.orgExperienced theft by support person
  100326-8 iconhttp://loinc.orgMoney spent or property sold without permission
  100327-6 iconhttp://loinc.orgStranger forged signature for financial gain
  100328-4 iconhttp://loinc.orgStranger forced document signature for financial gain
  100329-2 iconhttp://loinc.orgFeared for safety due to verbal attack
  1003-3 iconhttp://loinc.orgIndirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma
  100330-0 iconhttp://loinc.orgFelt humiliated due to ridicule
  100331-8 iconhttp://loinc.orgCoerced to do something
  100332-6 iconhttp://loinc.orgIgnored by close friend or relative for extended period
  100333-4 iconhttp://loinc.orgPhysically hit or threatened
  100334-2 iconhttp://loinc.orgBeen physically hurt with some degree of injury
  100335-9 iconhttp://loinc.orgCoerced sexual activity
  100336-7 iconhttp://loinc.orgCoerced touching of private body parts of self or others
  100337-5 iconhttp://loinc.orgCoerced to undress or expose private body area
  100338-3 iconhttp://loinc.orgPhotographed in any degree of nudity without consent
  10033-9 iconhttp://loinc.orgR' wave duration in lead V6
  100339-1 iconhttp://loinc.orgExperienced attempted physical restraint
  100340-9 iconhttp://loinc.orgRange of motion panel Hip
  100341-7 iconhttp://loinc.orgRubella virus IgG Ab index [Units/volume] in Serum and CSF
  100342-5 iconhttp://loinc.orgVolatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry
  100343-3 iconhttp://loinc.orgInfluenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
  100344-1 iconhttp://loinc.orgInfluenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
  100345-8 iconhttp://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
  100346-6 iconhttp://loinc.orgClotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG
  10034-7 iconhttp://loinc.orgS wave amplitude in lead AVF
  100347-4 iconhttp://loinc.orgClot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG
  100348-2 iconhttp://loinc.orgModel for end-stage liver disease sodium score
  100349-0 iconhttp://loinc.orgUS.doppler Penis vessels W vasodilator IV
  100350-8 iconhttp://loinc.orgSesamum indicum 1 IgE Ab [Units/volume] in Serum
  100351-6 iconhttp://loinc.orgPioglitazone [Presence] in Serum or Plasma
  100352-4 iconhttp://loinc.orgRosiglitazone [Presence] in Serum or Plasma
  100353-2 iconhttp://loinc.orgNorwalk Community Health Center Screening Tool [NCHC]
  10035-4 iconhttp://loinc.orgS wave amplitude in lead AVL
  100354-0 iconhttp://loinc.orgFrequency of participating in multi-modal communication without assistance
  100355-7 iconhttp://loinc.orgFrequency of participating in spoken language expression communication without assistance
  100356-5 iconhttp://loinc.orgChlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection
  100357-3 iconhttp://loinc.orgNaloxone [Presence] in Cord tissue by Screen method
  100358-1 iconhttp://loinc.orgPhentermine [Presence] in Cord tissue by Screen method
  100359-9 iconhttp://loinc.orgGliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay
  100360-7 iconhttp://loinc.orgBrief Resilience Scale panel [BRS]
  100361-5 iconhttp://loinc.orgQuickly recover from bad events
  10036-2 iconhttp://loinc.orgS wave amplitude in lead AVR
  100362-3 iconhttp://loinc.orgDifficulty making it through stressful events
  100363-1 iconhttp://loinc.orgEasily recover from a stressful event
  100364-9 iconhttp://loinc.orgDifficulty recovering from bad events
  100365-6 iconhttp://loinc.orgEasily recover from difficulties
  100366-4 iconhttp://loinc.orgLengthy recovery from setbacks
  100367-2 iconhttp://loinc.orgTotal Score BRS
  100368-0 iconhttp://loinc.orgAmino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS
  100369-8 iconhttp://loinc.orgNM Thyroid gland Views W Tl-201 IV
  10037-0 iconhttp://loinc.orgS wave amplitude in lead I
  100370-6 iconhttp://loinc.orgOrthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection
  100371-4 iconhttp://loinc.orgTitin Ab [Units/volume] in Serum by Immunoassay
  100372-2 iconhttp://loinc.orgAbiraterone [Mass/volume] in Serum or Plasma
  100373-0 iconhttp://loinc.orgEucheuma IgG Ab [Units/volume] in Serum
  100374-8 iconhttp://loinc.orgAloe vera IgG Ab [Units/volume] in Serum
  100375-5 iconhttp://loinc.orgAnise IgG Ab [Units/volume] in Serum
  100376-3 iconhttp://loinc.orgBambusa vulgaris IgG Ab [Units/volume] in Serum
  100377-1 iconhttp://loinc.orgGoat cheese IgG Ab [Units/volume] in Serum
  100378-9 iconhttp://loinc.orgSheep cheese IgG Ab [Units/volume] in Serum
  100379-7 iconhttp://loinc.orgLeeks IgG Ab [Units/volume] in Serum
  100380-5 iconhttp://loinc.orgRed cabbage IgG Ab [Units/volume] in Serum
  100381-3 iconhttp://loinc.orgMentha balsamea Wild IgG Ab [Units/volume] in Serum
  100382-1 iconhttp://loinc.orgFDA package insert REMS addressed risk
  100383-9 iconhttp://loinc.orgMonkeypox virus DNA [Presence] in Specimen by NAA with probe detection
  100384-7 iconhttp://loinc.orgRapeseed IgG Ab [Units/volume] in Serum
  100385-4 iconhttp://loinc.orgCorn salad IgG Ab [Units/volume] in Serum
  100386-2 iconhttp://loinc.orgRosemary IgG Ab [Units/volume] in Serum
  100387-0 iconhttp://loinc.orgPoppy Seed IgG Ab [Units/volume] in Serum
  10038-8 iconhttp://loinc.orgS wave amplitude in lead II
  100388-8 iconhttp://loinc.orgCocoa IgG Ab [Units/volume] in Serum
  100389-6 iconhttp://loinc.orgPistachio IgG Ab [Units/volume] in Serum
  100390-4 iconhttp://loinc.orgSunflower Seed IgG Ab [Units/volume] in Serum
  100391-2 iconhttp://loinc.orgDates IgG Ab [Units/volume] in Serum
  100392-0 iconhttp://loinc.orgDuck meat IgG Ab [Units/volume] in Serum
  100393-8 iconhttp://loinc.orgAllergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum
  100394-6 iconhttp://loinc.orgAstacoidea IgG Ab [Units/volume] in Serum
  100395-3 iconhttp://loinc.orgCarob IgG Ab [Units/volume] in Serum
  10039-6 iconhttp://loinc.orgS wave amplitude in lead III
  100396-1 iconhttp://loinc.orgBrassica napus IgG Ab [Units/volume] in Serum
  100397-9 iconhttp://loinc.orgGoat Meat IgG Ab [Units/volume] in Serum
  100398-7 iconhttp://loinc.orgGoose meat IgG Ab [Units/volume] in Serum
  100399-5 iconhttp://loinc.orgOstrich meat IgG Ab [Units/volume] in Serum
  100400-1 iconhttp://loinc.orgQuail meat IgG Ab [Units/volume] in Serum
  100401-9 iconhttp://loinc.orgRabbit meat IgG Ab [Units/volume] in Serum
  100402-7 iconhttp://loinc.orgVenison meat IgG Ab [Units/volume] in Serum
  100403-5 iconhttp://loinc.orgGuineafowl IgG Ab [Units/volume] in Serum
  10040-4 iconhttp://loinc.orgS wave amplitude in lead V1
  100404-3 iconhttp://loinc.orgHorse meat IgG Ab [Units/volume] in Serum
  100405-0 iconhttp://loinc.orgKefir IgG Ab [Units/volume] in Serum
  100406-8 iconhttp://loinc.orgButter IgG Ab [Units/volume] in Serum
  100407-6 iconhttp://loinc.orgCamembert cheese IgG Ab [Units/volume] in Serum
  100408-4 iconhttp://loinc.orgEmmental cheese IgG Ab [Units/volume] in Serum
  100409-2 iconhttp://loinc.orgProcessed cheese IgG Ab [Units/volume] in Serum
  1004-1 iconhttp://loinc.orgDirect antiglobulin test.complement specific reagent [Presence] on Red Blood Cells
  100410-0 iconhttp://loinc.orgCurd cheese IgG Ab [Units/volume] in Serum
  100411-8 iconhttp://loinc.orgSugar Beet IgG Ab [Units/volume] in Serum
  10041-2 iconhttp://loinc.orgS wave amplitude in lead V2
  100412-6 iconhttp://loinc.orgChinese cabbage IgG Ab [Units/volume] in Serum
  100413-4 iconhttp://loinc.orgFennel Fresh IgG Ab [Units/volume] in Serum
  100414-2 iconhttp://loinc.orgGourd IgG Ab [Units/volume] in Serum
  100415-9 iconhttp://loinc.orgKale IgG Ab [Units/volume] in Serum
  100416-7 iconhttp://loinc.orgSavoy cabbage IgG Ab [Units/volume] in Serum
  100417-5 iconhttp://loinc.orgVitis sp leaf IgG Ab [Units/volume] in Serum
  100418-3 iconhttp://loinc.orgLiquorice IgG Ab [Units/volume] in Serum
  100419-1 iconhttp://loinc.orgSnow pea IgG Ab [Units/volume] in Serum
  10042-0 iconhttp://loinc.orgS wave amplitude in lead V3
  100420-9 iconhttp://loinc.orgFava bean IgG Ab [Units/volume] in Serum
  100421-7 iconhttp://loinc.orgChick Pea IgG Ab [Units/volume] in Serum
  100422-5 iconhttp://loinc.orgChicory IgG Ab [Units/volume] in Serum
  100423-3 iconhttp://loinc.orgAllergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum
  100424-1 iconhttp://loinc.org8(9)-Cholestenol [Mass/volume] in Serum or Plasma
  100425-8 iconhttp://loinc.orgDiHydro T-Mas [Mass/volume] in Serum or Plasma
  100426-6 iconhttp://loinc.orgSqualene [Mass/volume] in Serum or Plasma
  100427-4 iconhttp://loinc.orgStigmasterol [Mass/volume] in Serum or Plasma
  100428-2 iconhttp://loinc.orgCarnitine free and total and acylcarnitine panel - Urine
  100429-0 iconhttp://loinc.orgLRBA deficiency panel - Blood
  100430-8 iconhttp://loinc.orgCells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC)
  100431-6 iconhttp://loinc.orgCells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
  100432-4 iconhttp://loinc.orgCells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC)
  100433-2 iconhttp://loinc.orgCells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
  100434-0 iconhttp://loinc.orgOrthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection
  100435-7 iconhttp://loinc.orgGlial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay
  100436-5 iconhttp://loinc.orgUbiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay
  100437-3 iconhttp://loinc.orgNorsufentanil [Mass/volume] in Urine by Confirmatory method
  10043-8 iconhttp://loinc.orgS wave amplitude in lead V4
  100438-1 iconhttp://loinc.orgAdolescent medicine Outpatient Progress note
  100439-9 iconhttp://loinc.orgAllergy and Immunology Outpatient Progress note
  100440-7 iconhttp://loinc.orgAllergy Outpatient Progress note
  100441-5 iconhttp://loinc.orgAttending Outpatient Progress note
  100442-3 iconhttp://loinc.orgAudiology Outpatient Progress note
  100443-1 iconhttp://loinc.orgBariatric surgery Outpatient Progress note
  100444-9 iconhttp://loinc.orgBlood banking and transfusion medicine Outpatient Progress note
  100445-6 iconhttp://loinc.orgBone Marrow Transplant Outpatient Progress note
  10044-6 iconhttp://loinc.orgS wave amplitude in lead V5
  100446-4 iconhttp://loinc.orgBreastfeeding Outpatient Progress note
  100447-2 iconhttp://loinc.orgBurn management Outpatient Progress note
  100448-0 iconhttp://loinc.orgCardiac surgery Outpatient Progress note
  100449-8 iconhttp://loinc.orgCardiopulmonary Outpatient Progress note
  100450-6 iconhttp://loinc.orgChild and adolescent psychiatry Outpatient Progress note
  100451-4 iconhttp://loinc.orgChiropractic medicine Outpatient Progress note
  100452-2 iconhttp://loinc.orgClinical cardiac electrophysiology Outpatient Progress note
  10045-3 iconhttp://loinc.orgS wave amplitude in lead V6
  100453-0 iconhttp://loinc.orgClinical genetics Outpatient Progress note
  100454-8 iconhttp://loinc.orgClinical neurophysiology Outpatient Progress note
  100455-5 iconhttp://loinc.orgClinical pathology Outpatient Progress note
  100456-3 iconhttp://loinc.orgColon and rectal surgery Outpatient Progress note
  100457-1 iconhttp://loinc.orgConsultant Outpatient Progress note
  100458-9 iconhttp://loinc.orgOutpatient COVID-19 Intubation Progress note
  100459-7 iconhttp://loinc.orgOutpatient COVID-19 Progress note
  100460-5 iconhttp://loinc.orgDermatology Outpatient Progress note
  10046-1 iconhttp://loinc.orgS wave duration in lead AVF
  100461-3 iconhttp://loinc.orgDevelopmental-behavioral pediatrics Outpatient Progress note
  100462-1 iconhttp://loinc.orgDialysis and Therapeutic apheresis Outpatient Progress note
  100463-9 iconhttp://loinc.orgEating disorders Outpatient Progress note
  100464-7 iconhttp://loinc.orgEndocrinology Outpatient Progress note
  100465-4 iconhttp://loinc.orgFamily medicine Outpatient Progress note
  100466-2 iconhttp://loinc.orgGastroenterology Outpatient Progress note
  100467-0 iconhttp://loinc.orgGeriatric medicine Outpatient Progress note
  100468-8 iconhttp://loinc.orgGynecologic oncology Outpatient Progress note
  100469-6 iconhttp://loinc.orgGynecology Outpatient Progress note
  100470-4 iconhttp://loinc.orgHealthcare navigator Outpatient Progress note
  100471-2 iconhttp://loinc.orgHeart failure Outpatient Progress note
  100472-0 iconhttp://loinc.orgHeart failure+Transplant cardiology Outpatient Progress note
  100473-8 iconhttp://loinc.orgHematology Outpatient Progress note
  100474-6 iconhttp://loinc.orgHematology+Medical oncology Outpatient Progress note
  100475-3 iconhttp://loinc.orgHepatology Outpatient Progress note
  100476-1 iconhttp://loinc.orgImmunology Outpatient Progress note
  100477-9 iconhttp://loinc.orgInfectious disease Outpatient Progress note
  100478-7 iconhttp://loinc.orgInternal medicine Outpatient Progress note
  10047-9 iconhttp://loinc.orgS wave duration in lead AVL
  100479-5 iconhttp://loinc.orgInterventional cardiology Outpatient Progress note
  100480-3 iconhttp://loinc.orgInterventional radiology Outpatient Progress note
  100481-1 iconhttp://loinc.orgOutpatient Mechanical circulatory support Progress note
  100482-9 iconhttp://loinc.orgMedical Aid in Dying Outpatient Progress note
  100483-7 iconhttp://loinc.orgMental health Outpatient Progress note
  100484-5 iconhttp://loinc.orgMulti-specialty program Outpatient Progress note
  100485-2 iconhttp://loinc.orgNeonatal perinatal medicine Outpatient Progress note
  100486-0 iconhttp://loinc.orgNephrology Outpatient Progress note
  10048-7 iconhttp://loinc.orgS wave duration in lead AVR
  100487-8 iconhttp://loinc.orgNeurological surgery Outpatient Progress note
  100488-6 iconhttp://loinc.orgNeurology Outpatient Progress note
  100489-4 iconhttp://loinc.orgNeurology with special qualifications in child neurology Outpatient Progress note
  100490-2 iconhttp://loinc.orgNurse practitioner Outpatient Progress note
  100491-0 iconhttp://loinc.orgNurse Outpatient Progress note
  100492-8 iconhttp://loinc.orgNutrition and dietetics Outpatient Progress note
  100493-6 iconhttp://loinc.orgObstetrics and Gynecology Outpatient Progress note
  100494-4 iconhttp://loinc.orgObstetrics Outpatient Progress note
  10049-5 iconhttp://loinc.orgS wave duration in lead I
  100495-1 iconhttp://loinc.orgOccupational therapy Outpatient Progress note
  100496-9 iconhttp://loinc.orgOncology Outpatient Progress note
  100497-7 iconhttp://loinc.orgOphthalmology Outpatient Progress note
  100498-5 iconhttp://loinc.orgOptometry Outpatient Progress note
  100499-3 iconhttp://loinc.orgOral and Maxillofacial Surgery Outpatient Progress note
  100500-8 iconhttp://loinc.orgOrthopaedic surgery Outpatient Progress note
  100501-6 iconhttp://loinc.orgOrthotics prosthetics Outpatient Progress note
  100502-4 iconhttp://loinc.orgOtolaryngology Outpatient Progress note
  10050-3 iconhttp://loinc.orgS wave duration in lead II
  100503-2 iconhttp://loinc.orgPain medicine Outpatient Progress note
  100504-0 iconhttp://loinc.orgPalliative care Outpatient Progress note
  100505-7 iconhttp://loinc.orgPediatric cardiology Outpatient Progress note
  100506-5 iconhttp://loinc.orgPediatric dermatology Outpatient Progress note
  100507-3 iconhttp://loinc.orgPediatric endocrinology Outpatient Progress note
  100508-1 iconhttp://loinc.orgPediatric gastroenterology Outpatient Progress note
  100509-9 iconhttp://loinc.orgPediatric hematology-oncology Outpatient Progress note
  100510-7 iconhttp://loinc.orgPediatric infectious diseases Outpatient Progress note
  10051-1 iconhttp://loinc.orgS wave duration in lead III
  100511-5 iconhttp://loinc.orgPediatric otolaryngology Outpatient Progress note
  100512-3 iconhttp://loinc.orgPediatric pulmonology Outpatient Progress note
  100513-1 iconhttp://loinc.orgPediatric rheumatology Outpatient Progress note
  100514-9 iconhttp://loinc.orgPediatric surgery Outpatient Progress note
  100515-6 iconhttp://loinc.orgPediatric transplant hepatology Outpatient Progress note
  100516-4 iconhttp://loinc.orgPediatric urology Outpatient Progress note
  100517-2 iconhttp://loinc.orgPharmacogenomics Outpatient Progress note
  100518-0 iconhttp://loinc.orgPhysical medicine and rehab Outpatient Progress note
  100519-8 iconhttp://loinc.orgPhysical therapy Outpatient Progress note
  100520-6 iconhttp://loinc.orgPlastic surgery Outpatient Progress note
  100521-4 iconhttp://loinc.orgPodiatry Outpatient Progress note
  100522-2 iconhttp://loinc.orgPsychiatry Hospital Progress note
  100523-0 iconhttp://loinc.orgPsychology Outpatient Progress note
  100524-8 iconhttp://loinc.orgPulmonary Outpatient Progress note
  100525-5 iconhttp://loinc.orgRadiation oncology Outpatient Progress note
  100526-3 iconhttp://loinc.orgRadiology Outpatient Progress note
  100527-1 iconhttp://loinc.orgRecreational therapy Outpatient Progress note
  100528-9 iconhttp://loinc.orgReproductive endocrinology and infertility Outpatient Progress note
  10052-9 iconhttp://loinc.orgS wave duration in lead V1
  100529-7 iconhttp://loinc.orgResearch Outpatient Progress note
  100530-5 iconhttp://loinc.orgRheumatology Outpatient Progress note
  100531-3 iconhttp://loinc.orgSleep medicine Outpatient Progress note
  100532-1 iconhttp://loinc.orgSocial worker Outpatient Progress note
  100533-9 iconhttp://loinc.orgSolid Organ Transplant Outpatient Progress note
  100534-7 iconhttp://loinc.orgSpeech-language pathology Outpatient Progress note
  100535-4 iconhttp://loinc.orgSpinal surgery Outpatient Progress note
  100536-2 iconhttp://loinc.orgSports medicine Outpatient Progress note
  10053-7 iconhttp://loinc.orgS wave duration in lead V2
  100537-0 iconhttp://loinc.orgSurgery of the hand Outpatient Progress note
  100538-8 iconhttp://loinc.orgTelehealth+Outpatient Progress note
  100539-6 iconhttp://loinc.orgThromboembolism Outpatient Progress note
  100540-4 iconhttp://loinc.orgTransplant surgery Outpatient Progress note
  100541-2 iconhttp://loinc.orgTrauma Outpatient Progress note
  100542-0 iconhttp://loinc.orgUrology Outpatient Progress note
  100543-8 iconhttp://loinc.orgVascular neurology Outpatient Progress note
  100544-6 iconhttp://loinc.orgVascular surgery Outpatient Progress note
  10054-5 iconhttp://loinc.orgS wave duration in lead V3
  100545-3 iconhttp://loinc.orgWound care management Outpatient Progress note
  100546-1 iconhttp://loinc.orgWound, Ostomy, and Continence Care Outpatient Progress note
  100547-9 iconhttp://loinc.orgAdolescent medicine Hospital Progress note
  100548-7 iconhttp://loinc.orgAllergy and Immunology Hospital Progress note
  100549-5 iconhttp://loinc.orgAllergy Hospital Progress note
  100550-3 iconhttp://loinc.orgAttending Hospital Progress note
  100551-1 iconhttp://loinc.orgAudiology Hospital Progress note
  10055-2 iconhttp://loinc.orgS wave duration in lead V4
  100552-9 iconhttp://loinc.orgBariatric surgery Hospital Progress note
  100553-7 iconhttp://loinc.orgBlood banking and transfusion medicine Hospital Progress note
  100554-5 iconhttp://loinc.orgBone Marrow Transplant Hospital Progress note
  100555-2 iconhttp://loinc.orgBreastfeeding Hospital Progress note
  100556-0 iconhttp://loinc.orgBurn management Hospital Progress note
  100557-8 iconhttp://loinc.orgCardiac surgery Hospital Progress note
  100558-6 iconhttp://loinc.orgCardiopulmonary Hospital Progress note
  100559-4 iconhttp://loinc.orgChild and adolescent psychiatry Hospital Progress note
  10056-0 iconhttp://loinc.orgS wave duration in lead V5
  100560-2 iconhttp://loinc.orgClinical cardiac electrophysiology Hospital Progress note
  100561-0 iconhttp://loinc.orgClinical genetics Hospital Progress note
  100562-8 iconhttp://loinc.orgClinical neurophysiology Hospital Progress note
  100563-6 iconhttp://loinc.orgClinical pathology Hospital Progress note
  100564-4 iconhttp://loinc.orgColon and rectal surgery Hospital Progress note
  100565-1 iconhttp://loinc.orgConsultant Hospital Progress note
  100566-9 iconhttp://loinc.orgDentistry Hospital Progress note
  100567-7 iconhttp://loinc.orgDermatology Hospital Progress note
  100568-5 iconhttp://loinc.orgDevelopmental-behavioral pediatrics Hospital Progress note
  100569-3 iconhttp://loinc.orgDialysis and Therapeutic apheresis Hospital Progress note
  100570-1 iconhttp://loinc.orgEating disorders Hospital Progress note
  100571-9 iconhttp://loinc.orgEndocrinology Hospital Progress note
  100572-7 iconhttp://loinc.orgFamily medicine Hospital Progress note
  100573-5 iconhttp://loinc.orgGastroenterology Hospital Progress note
  100574-3 iconhttp://loinc.orgGeneral medicine Hospital Progress note
  100575-0 iconhttp://loinc.orgGeriatric medicine Hospital Progress note
  100576-8 iconhttp://loinc.orgGynecologic oncology Hospital Progress note
  100577-6 iconhttp://loinc.orgGynecology Hospital Progress note
  10057-8 iconhttp://loinc.orgS wave duration in lead V6
  100578-4 iconhttp://loinc.orgHealthcare navigator Hospital Progress note
  100579-2 iconhttp://loinc.orgHeart failure Hospital Progress note
  1005-8 iconhttp://loinc.orgIndirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma
  100580-0 iconhttp://loinc.orgHeart failure+Transplant cardiology Hospital Progress note
  100581-8 iconhttp://loinc.orgHematology Hospital Progress note
  100582-6 iconhttp://loinc.orgHematology+Medical oncology Hospital Progress note
  100583-4 iconhttp://loinc.orgHepatology Hospital Progress note
  100584-2 iconhttp://loinc.orgImmunology Hospital Progress note
  100585-9 iconhttp://loinc.orgInfectious disease Hospital Progress note
  10058-6 iconhttp://loinc.orgS' wave amplitude in lead AVF
  100586-7 iconhttp://loinc.orgInternal medicine Hospital Progress note
  100587-5 iconhttp://loinc.orgInterventional cardiology Hospital Progress note
  100588-3 iconhttp://loinc.orgInterventional radiology Hospital Progress note
  100589-1 iconhttp://loinc.orgHospital Mechanical circulatory support Progress note
  100590-9 iconhttp://loinc.orgMedical Aid in Dying Hospital Progress note
  100591-7 iconhttp://loinc.orgMental health Hospital Progress note
  100592-5 iconhttp://loinc.orgMulti-specialty program Hospital Progress note
  100593-3 iconhttp://loinc.orgNeonatal perinatal medicine Hospital Progress note
  10059-4 iconhttp://loinc.orgS' wave amplitude in lead AVL
  100594-1 iconhttp://loinc.orgNephrology Hospital Progress note
  100595-8 iconhttp://loinc.orgNeurological surgery Hospital Progress note
  100596-6 iconhttp://loinc.orgNeurology Hospital Progress note
  100597-4 iconhttp://loinc.orgNeurology with special qualifications in child neurology Hospital Progress note
  100598-2 iconhttp://loinc.orgNurse practitioner Hospital Progress note
  100599-0 iconhttp://loinc.orgNurse Hospital Progress note
  100600-6 iconhttp://loinc.orgNutrition and dietetics Hospital Progress note
  100601-4 iconhttp://loinc.orgObstetrics and Gynecology Hospital Progress note
  10060-2 iconhttp://loinc.orgS' wave amplitude in lead AVR
  100602-2 iconhttp://loinc.orgObstetrics Hospital Progress note
  100603-0 iconhttp://loinc.orgOccupational therapy Hospital Progress note
  100604-8 iconhttp://loinc.orgOncology Hospital Progress note
  100605-5 iconhttp://loinc.orgOphthalmology Hospital Progress note
  100606-3 iconhttp://loinc.orgOral and Maxillofacial Surgery Hospital Progress note
  100607-1 iconhttp://loinc.orgOrthopaedic surgery Hospital Progress note
  100608-9 iconhttp://loinc.orgOrthotics prosthetics Hospital Progress note
  100609-7 iconhttp://loinc.orgOtolaryngology Hospital Progress note
  10061-0 iconhttp://loinc.orgS' wave amplitude in lead I
  100610-5 iconhttp://loinc.orgPain medicine Hospital Progress note
  100611-3 iconhttp://loinc.orgPalliative care Hospital Progress note
  100612-1 iconhttp://loinc.orgPastoral care Hospital Progress note
  100613-9 iconhttp://loinc.orgPediatric cardiology Hospital Progress note
  100614-7 iconhttp://loinc.orgPediatric dermatology Hospital Progress note
  100615-4 iconhttp://loinc.orgPediatric endocrinology Hospital Progress note
  100616-2 iconhttp://loinc.orgPediatric gastroenterology Hospital Progress note
  100617-0 iconhttp://loinc.orgPediatric hematology-oncology Hospital Progress note
  100618-8 iconhttp://loinc.orgPediatric infectious diseases Hospital Progress note
  100619-6 iconhttp://loinc.orgPediatric otolaryngology Hospital Progress note
  100620-4 iconhttp://loinc.orgPediatric pulmonology Hospital Progress note
  100621-2 iconhttp://loinc.orgPediatric rheumatology Hospital Progress note
  100622-0 iconhttp://loinc.orgPediatric surgery Hospital Progress note
  100623-8 iconhttp://loinc.orgPediatric transplant hepatology Hospital Progress note
  100624-6 iconhttp://loinc.orgPharmacogenomics Hospital Progress note
  100625-3 iconhttp://loinc.orgPharmacology Hospital Progress note
  100626-1 iconhttp://loinc.orgPhysical medicine and rehab Hospital Progress note
  100627-9 iconhttp://loinc.orgPhysical therapy Hospital Progress note
  10062-8 iconhttp://loinc.orgS' wave amplitude in lead II
  100628-7 iconhttp://loinc.orgPlastic surgery Hospital Progress note
  100629-5 iconhttp://loinc.orgPodiatry Hospital Progress note
  100630-3 iconhttp://loinc.orgPsychology Hospital Progress note
  100631-1 iconhttp://loinc.orgRadiation oncology Hospital Progress note
  100632-9 iconhttp://loinc.orgRadiology Hospital Progress note
  100633-7 iconhttp://loinc.orgRapid response team Hospital Progress note
  100634-5 iconhttp://loinc.orgRecreational therapy Hospital Progress note
  100635-2 iconhttp://loinc.orgReproductive endocrinology and infertility Hospital Progress note
  10063-6 iconhttp://loinc.orgS' wave amplitude in lead III
  100636-0 iconhttp://loinc.orgResearch Hospital Progress note
  100637-8 iconhttp://loinc.orgRheumatology Hospital Progress note
  100638-6 iconhttp://loinc.orgSleep medicine Hospital Progress note
  100639-4 iconhttp://loinc.orgSocial worker Hospital Progress note
  100640-2 iconhttp://loinc.orgSolid Organ Transplant Hospital Progress note
  100641-0 iconhttp://loinc.orgSpeech-language pathology Hospital Progress note
  100642-8 iconhttp://loinc.orgSpinal surgery Hospital Progress note
  100643-6 iconhttp://loinc.orgSurgery of the hand Hospital Progress note
  10064-4 iconhttp://loinc.orgS' wave amplitude in lead V1
  100644-4 iconhttp://loinc.orgThromboembolism Hospital Progress note
  100645-1 iconhttp://loinc.orgTrauma Hospital Progress note
  100646-9 iconhttp://loinc.orgUrology Hospital Progress note
  100647-7 iconhttp://loinc.orgVascular neurology Hospital Progress note
  100648-5 iconhttp://loinc.orgVascular surgery Hospital Progress note
  100649-3 iconhttp://loinc.orgWound care management Hospital Progress note
  100650-1 iconhttp://loinc.orgWound, Ostomy, and Continence Care Hospital Progress note
  10065-1 iconhttp://loinc.orgS' wave amplitude in lead V2
  100651-9 iconhttp://loinc.orgHospital COVID-19 Intubation Progress note
  100652-7 iconhttp://loinc.orgPure tone bone conduction threshold audiometry panel
  100653-5 iconhttp://loinc.orgPure tone air conduction threshold audiometry panel
  100654-3 iconhttp://loinc.orgPyruvate kinase M2 [Presence] in Stool
  100655-0 iconhttp://loinc.orgXR Sella turcica Lateral
  100656-8 iconhttp://loinc.orgMaternal and fetal medicine Outpatient Progress note
  100657-6 iconhttp://loinc.orgMaternal and fetal medicine Telephone encounter+Hospital Progress note
  100658-4 iconhttp://loinc.orgHospital COVID-19 Progress note
  100659-2 iconhttp://loinc.orgMaternal and fetal medicine Hospital Progress note
  1006-6 iconhttp://loinc.orgDirect antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells
  100660-0 iconhttp://loinc.orgMaternal and fetal medicine Telephone encounter+Outpatient Progress note
  100661-8 iconhttp://loinc.orgPsychiatry Outpatient Progress note
  100662-6 iconhttp://loinc.orgCortisol free and total panel - Serum or Plasma
  100663-4 iconhttp://loinc.orgTPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method
  100664-2 iconhttp://loinc.orgNUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method
  100665-9 iconhttp://loinc.orgNUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method
  100666-7 iconhttp://loinc.orgNUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method
  100667-5 iconhttp://loinc.orgNUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method
  100668-3 iconhttp://loinc.orgNUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method
  10066-9 iconhttp://loinc.orgS' wave amplitude in lead V3
  100669-1 iconhttp://loinc.orgNUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method
  100670-9 iconhttp://loinc.orgRHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus
  100671-7 iconhttp://loinc.orgAspergillus sp DNA [Presence] in Blood by NAA with probe detection
  100672-5 iconhttp://loinc.orgAspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection
  100673-3 iconhttp://loinc.orgAspergillus terreus DNA [Presence] in Blood by NAA with probe detection
  100674-1 iconhttp://loinc.orgBK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100675-8 iconhttp://loinc.orgCytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
  100676-6 iconhttp://loinc.orgCytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection
  10067-7 iconhttp://loinc.orgS' wave amplitude in lead V4
  100677-4 iconhttp://loinc.orgEpstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100678-2 iconhttp://loinc.orgEpstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100679-0 iconhttp://loinc.orgHerpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100680-8 iconhttp://loinc.orgHerpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100681-6 iconhttp://loinc.orgHerpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100682-4 iconhttp://loinc.orgHerpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100683-2 iconhttp://loinc.orgHerpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100684-0 iconhttp://loinc.orgHerpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  10068-5 iconhttp://loinc.orgS' wave amplitude in lead V5
  100685-7 iconhttp://loinc.orgJC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100686-5 iconhttp://loinc.orgJC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
  100687-3 iconhttp://loinc.orgJC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection
  100688-1 iconhttp://loinc.orgParvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100689-9 iconhttp://loinc.orgToxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection
  100690-7 iconhttp://loinc.orgToxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection
  100691-5 iconhttp://loinc.orgVaricella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100692-3 iconhttp://loinc.orgVaricella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
  10069-3 iconhttp://loinc.orgS' wave amplitude in lead V6
  100693-1 iconhttp://loinc.orgPneumocystis jiroveci DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection
  100694-9 iconhttp://loinc.orgSMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method
  100695-6 iconhttp://loinc.orgGenetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative
  100696-4 iconhttp://loinc.orgCTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal
  100697-2 iconhttp://loinc.orgInterventional radiology Outpatient Note
  100698-0 iconhttp://loinc.orgSocial Determinants of Health screening report Document
  100699-8 iconhttp://loinc.orgRifabutin+Ethambutol [Susceptibility]
  100700-4 iconhttp://loinc.orgTrichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection
  10070-1 iconhttp://loinc.orgS' wave duration in lead AVF
  100701-2 iconhttp://loinc.orgTrichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection
  100702-0 iconhttp://loinc.orgMycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection
  100703-8 iconhttp://loinc.orgMycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection
  100704-6 iconhttp://loinc.orgMycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection
  100705-3 iconhttp://loinc.orgMycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection
  100706-1 iconhttp://loinc.orgMycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection
  100707-9 iconhttp://loinc.orgPolymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count
  100708-7 iconhttp://loinc.orgPlasma cells/100 leukocytes in Synovial fluid
  100709-5 iconhttp://loinc.orgHepatocellular carcinoma risk [Score] by GAAD
  100710-3 iconhttp://loinc.orgChlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection
  100711-1 iconhttp://loinc.orgBorrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay
  100712-9 iconhttp://loinc.orgBrexpiprazole [Mass/volume] in Serum or Plasma
  100713-7 iconhttp://loinc.orgCariprazine [Mass/volume] in Serum or Plasma
  100714-5 iconhttp://loinc.orgGuanfacine [Mass/volume] in Serum or Plasma
  100715-2 iconhttp://loinc.orgProthipendyl [Mass/volume] in Serum or Plasma
  100716-0 iconhttp://loinc.orgProstate specific Ag [Mass/volume] in DBS
  100717-8 iconhttp://loinc.orgFCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method
  100718-6 iconhttp://loinc.orgUndersea and hyperbaric medicine Discharge summary
  10071-9 iconhttp://loinc.orgS' wave duration in lead AVL
  100719-4 iconhttp://loinc.orgSurgical oncology Discharge summary
  100720-2 iconhttp://loinc.orgReproductive endocrinology and infertility Discharge summary
  100721-0 iconhttp://loinc.orgCommunity health care Discharge summary
  100722-8 iconhttp://loinc.orgIntegrative medicine Discharge summary
  100723-6 iconhttp://loinc.orgSports medicine Discharge summary
  100724-4 iconhttp://loinc.orgDiabetology Discharge summary
  100725-1 iconhttp://loinc.orgOptometry Discharge summary
  100726-9 iconhttp://loinc.orgPodiatry Discharge summary
  10072-7 iconhttp://loinc.orgS' wave duration in lead AVR
  100727-7 iconhttp://loinc.orgChiropractic medicine Discharge summary
  100728-5 iconhttp://loinc.orgCardiac surgery Discharge summary
  100729-3 iconhttp://loinc.orgBreastfeeding Discharge summary
  100730-1 iconhttp://loinc.orgTransplant surgery Discharge summary
  100731-9 iconhttp://loinc.orgUrgent care center Discharge summary
  100732-7 iconhttp://loinc.orgCholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum
  100733-5 iconhttp://loinc.orgCholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a)
  100734-3 iconhttp://loinc.orgtraMADol and Metabolites Panel - Urine by Confirmatory method
  10073-5 iconhttp://loinc.orgS' wave duration in lead I
  100735-0 iconhttp://loinc.orgMannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes
  100736-8 iconhttp://loinc.orgAcylcarnitine Analysis Post Mortem in Specimen Document
  100737-6 iconhttp://loinc.orgAlkaline phosphatase.macromolecular [Presence] in Serum or Plasma
  100738-4 iconhttp://loinc.orgAlanine aminotransferase.macromolecular [Presence] in Serum or Plasma
  100739-2 iconhttp://loinc.orgAspartate aminotransferase.macromolecular [Presence] in Serum or Plasma
  1007-4 iconhttp://loinc.orgDirect antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
  100740-0 iconhttp://loinc.orgAmylase.macromolecular [Presence] in Serum or Plasma
  100741-8 iconhttp://loinc.orgGamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma
  100742-6 iconhttp://loinc.orgLactate dehydrogenase.macromolecular [Presence] in Serum or Plasma
  10074-3 iconhttp://loinc.orgS' wave duration in lead II
  100743-4 iconhttp://loinc.orgLipase.macromolecular [Presence] in Serum or Plasma
  100744-2 iconhttp://loinc.orgAlpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis
  100745-9 iconhttp://loinc.orgChloride [Moles/volume] in Mixed venous blood
  100746-7 iconhttp://loinc.orgGlucose [Moles/volume] in Mixed venous blood
  100747-5 iconhttp://loinc.orgLegionella serogroup panel - Specimen
  100748-3 iconhttp://loinc.orgLegionella spp [Presence] in Specimen by NAA with probe detection
  100749-1 iconhttp://loinc.orgLegionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection
  10075-0 iconhttp://loinc.orgS' wave duration in lead III
  100750-9 iconhttp://loinc.orgLegionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection
  100751-7 iconhttp://loinc.orgGalactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma
  100752-5 iconhttp://loinc.orgExacerbating factors - Reported
  100753-3 iconhttp://loinc.orgAlleviating factors - Reported
  100754-1 iconhttp://loinc.orgPlatelet disorders multigene analysis in Blood or Tissue by Sequencing
  100755-8 iconhttp://loinc.orgOligoclonal bands [#] in Serum or Plasma by Isoelectric focusing
  100756-6 iconhttp://loinc.orgOligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing
  100757-4 iconhttp://loinc.orgProtein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing
  100758-2 iconhttp://loinc.orgEstimated lung age by based on clinical data
  100759-0 iconhttp://loinc.orgInspiratory reserve [Volume] Respiratory system by Spirometry
  100760-8 iconhttp://loinc.orgXR Radius and Ulna - left Single view
  100761-6 iconhttp://loinc.orgPALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
  100762-4 iconhttp://loinc.orgHBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method
  100763-2 iconhttp://loinc.orgMycobacterium sp comparative reaction interpretation Narrative
  100764-0 iconhttp://loinc.orgMycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal
  100765-7 iconhttp://loinc.orgHomocysteine and methylmalonate and methylcitrate panel - DBS
  100766-5 iconhttp://loinc.orgCenter for Epidemiologic Studies Depression Scale panel [CES-D]
  100767-3 iconhttp://loinc.orgBothered by things that are not usually bothersome
  10076-8 iconhttp://loinc.orgS' wave duration in lead V1
  100768-1 iconhttp://loinc.orgPoor appetite
  100769-9 iconhttp://loinc.orgUnhappy even with help from my family or friends
  100770-7 iconhttp://loinc.orgFeeling just as good as others
  100771-5 iconhttp://loinc.orgTrouble focusing
  100772-3 iconhttp://loinc.orgFeeling depressed
  100773-1 iconhttp://loinc.orgFeeling everything is too much of an effort
  100774-9 iconhttp://loinc.orgFeeling hopeful about the future
  100775-6 iconhttp://loinc.orgFeeling life had been a failure
  10077-6 iconhttp://loinc.orgS' wave duration in lead V2
  100776-4 iconhttp://loinc.orgFeeling fearful
  100777-2 iconhttp://loinc.orgRestless sleep
  100778-0 iconhttp://loinc.orgFeeling happy
  100779-8 iconhttp://loinc.orgQuieter than usual
  100780-6 iconhttp://loinc.orgFeeling lonely
  100781-4 iconhttp://loinc.orgPeople were unfriendly
  100782-2 iconhttp://loinc.orgEnjoying life
  100783-0 iconhttp://loinc.orgCrying spells
  10078-4 iconhttp://loinc.orgS' wave duration in lead V3
  100784-8 iconhttp://loinc.orgFeeling sad
  100785-5 iconhttp://loinc.orgFeeling people dislike me
  100786-3 iconhttp://loinc.orgLack of energy
  100787-1 iconhttp://loinc.orgTotal Score CES-D
  100788-9 iconhttp://loinc.orgStemphylium botryosum IgG4 Ab [Mass/volume] in Serum
  100789-7 iconhttp://loinc.orgRhizopus nigricans IgG4 Ab [Mass/volume] in Serum
  100790-5 iconhttp://loinc.orgLepidoglyphus destructor IgG Ab [Mass/volume] in Serum
  100791-3 iconhttp://loinc.orgHamster epithelium IgG Ab [Mass/volume] in Serum
  10079-2 iconhttp://loinc.orgS' wave duration in lead V4
  100792-1 iconhttp://loinc.orgForsythia IgE Ab [Units/volume] in Serum
  100793-9 iconhttp://loinc.orgTestosterone [Mass/volume] in Body fluid
  100794-7 iconhttp://loinc.orgFollitropin [Units/volume] in Body fluid
  100795-4 iconhttp://loinc.orgS100 calcium binding protein B [Mass/volume] in Body fluid
  100796-2 iconhttp://loinc.orgThyroglobulin [Mass/volume] in Body fluid
  100797-0 iconhttp://loinc.orgTestosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge
  100798-8 iconhttp://loinc.orgTestosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge
  100799-6 iconhttp://loinc.org21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge
  100-8 iconhttp://loinc.orgCefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
  10080-0 iconhttp://loinc.orgS' wave duration in lead V5
  100800-2 iconhttp://loinc.org21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge
  100801-0 iconhttp://loinc.org21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge
  100802-8 iconhttp://loinc.org21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge
  100803-6 iconhttp://loinc.org21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge
  100804-4 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge
  100805-1 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge
  100806-9 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge
  100807-7 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge
  100808-5 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge
  100809-3 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge
  100810-1 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge
  100811-9 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge
  100812-7 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge
  100813-5 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge
  100814-3 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge
  100815-0 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge
  100816-8 iconhttp://loinc.orgGlucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
  100817-6 iconhttp://loinc.orgGlucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
  10081-8 iconhttp://loinc.orgS' wave duration in lead V6
  100818-4 iconhttp://loinc.orgRenin [Mass/volume] in Plasma --1st specimen post XXX challenge
  100819-2 iconhttp://loinc.orgRenin [Mass/volume] in Plasma --2nd specimen post XXX challenge
  1008-2 iconhttp://loinc.orgIndirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma
  100820-0 iconhttp://loinc.orgRenin [Mass/volume] in Plasma --3rd specimen post XXX challenge
  100821-8 iconhttp://loinc.orgNational POLST form: portable medical order panel
  100822-6 iconhttp://loinc.orgCardiopulmonary resuscitation orders
  100823-4 iconhttp://loinc.orgInitial portable medical treatment orders
  100824-2 iconhttp://loinc.orgAdditional portable medical orders or instructions
  100825-9 iconhttp://loinc.orgMedically assisted nutrition orders
  10082-6 iconhttp://loinc.orgST initial amplitude 6 ms in lead AVF
  100826-7 iconhttp://loinc.orgPortable medical order AndOr advance directive review
  100827-5 iconhttp://loinc.orgPortable medical order discussion participants
  100828-3 iconhttp://loinc.orgPortable medical order administrative information
  100829-1 iconhttp://loinc.orgRenin [Mass/volume] in Plasma --4th specimen post XXX challenge
  100830-9 iconhttp://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
  100831-7 iconhttp://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
  100832-5 iconhttp://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
  100833-3 iconhttp://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
  10083-4 iconhttp://loinc.orgST initial amplitude 6 ms in lead AVL
  100834-1 iconhttp://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
  100835-8 iconhttp://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
  100836-6 iconhttp://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
  100837-4 iconhttp://loinc.orgInsulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
  100838-2 iconhttp://loinc.orgTestosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
  100839-0 iconhttp://loinc.orgVitamin A/Retinol binding protein [Ratio] in Serum or Plasma
  100840-8 iconhttp://loinc.orgIgE [Units/volume] in Body fluid
  100841-6 iconhttp://loinc.orgZinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot
  10084-2 iconhttp://loinc.orgST initial amplitude 6 ms in lead AVR
  100842-4 iconhttp://loinc.orgNonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST
  100843-2 iconhttp://loinc.orgLiver fibrosis score in Serum or Plasma by Calculated.Agile3+
  100844-0 iconhttp://loinc.orgLiver fibrosis score in Serum or Plasma by Calculated.Agile4
  100845-7 iconhttp://loinc.orgNeurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC)
  100846-5 iconhttp://loinc.orgDengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay
  100847-3 iconhttp://loinc.orgGas and ammonia panel - Arterial blood
  100848-1 iconhttp://loinc.orgCell count and Differential panel - Amniotic fluid by Manual count
  100849-9 iconhttp://loinc.orgLeukocytes [#/volume] in Amniotic fluid by Manual count
  100850-7 iconhttp://loinc.orgNeutrophils [#/volume] in Amniotic fluid by Manual count
  100851-5 iconhttp://loinc.orgOther cells [#/volume] in Amniotic fluid by Manual count
  100852-3 iconhttp://loinc.orgNM Bones Views for metastasis W Sr-89 IV
  100853-1 iconhttp://loinc.orgNM Pericardial space Pericardial effusion
  100854-9 iconhttp://loinc.orgLymphocytes/100 cells in Blood mononuclear cells by Immunoassay
  100855-6 iconhttp://loinc.orgCD3 cells/100 cells in Blood mononuclear cells
  100856-4 iconhttp://loinc.orgCD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells
  100857-2 iconhttp://loinc.orgCD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells
  100858-0 iconhttp://loinc.orgCells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  10085-9 iconhttp://loinc.orgST initial amplitude 6 ms in lead I
  100859-8 iconhttp://loinc.orgCells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  100860-6 iconhttp://loinc.orgCells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  100861-4 iconhttp://loinc.orgCells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100862-2 iconhttp://loinc.orgCells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100863-0 iconhttp://loinc.orgCells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100864-8 iconhttp://loinc.orgGiardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method
  100865-5 iconhttp://loinc.orgAvian schistosomes DNA [Presence] in Specimen by NAA with probe detection
  100866-3 iconhttp://loinc.orgFebrile antibody profile in Serum
  10086-7 iconhttp://loinc.orgST initial amplitude 6 ms in lead II
  100867-1 iconhttp://loinc.orgCampylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay
  100868-9 iconhttp://loinc.orgCryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method
  100869-7 iconhttp://loinc.orgCryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method
  100870-5 iconhttp://loinc.orgCryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method
  100871-3 iconhttp://loinc.orgGiardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method
  100872-1 iconhttp://loinc.orgBacteria producing polysaccharide from sucrose [Presence] in Isolate
  100873-9 iconhttp://loinc.orgGiardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method
  100874-7 iconhttp://loinc.orgBasidiobolus sp [Presence] in Specimen
  10087-5 iconhttp://loinc.orgST initial amplitude 6 ms in lead III
  100875-4 iconhttp://loinc.orgFetal Heart Document limited US
  100876-2 iconhttp://loinc.orgFetal Heart Document US
  100877-0 iconhttp://loinc.orgUS Heart Transesophageal during surgery
  100878-8 iconhttp://loinc.orgEndoscopic ultrasound study Upper GI tract Document
  100879-6 iconhttp://loinc.orgUS Guidance for cryoablation of Breast - right
  100880-4 iconhttp://loinc.orgUS Guidance for cryoablation of Breast - left
  100881-2 iconhttp://loinc.orgMR Guidance for cryoablation of Bone
  100882-0 iconhttp://loinc.orgMR Peritoneum W contrast percutaneous intraperitoneal
  10088-3 iconhttp://loinc.orgST initial amplitude 6 ms in lead V1
  100883-8 iconhttp://loinc.orgMR Guidance for biopsy of Kidney - left
  100884-6 iconhttp://loinc.orgMR Guidance for biopsy of Kidney - right
  100885-3 iconhttp://loinc.orgParapoxvirus DNA [Presence] in Specimen by NAA with probe detection
  100886-1 iconhttp://loinc.orgOrf virus DNA [Presence] in Specimen by NAA with probe detection
  100887-9 iconhttp://loinc.orgPseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection
  100888-7 iconhttp://loinc.orgMonkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection
  100889-5 iconhttp://loinc.orgMonkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection
  100890-3 iconhttp://loinc.orgPoxvirus DNA panel
  10089-1 iconhttp://loinc.orgST initial amplitude 6 ms in lead V2
  100891-1 iconhttp://loinc.orgOrthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay
  100892-9 iconhttp://loinc.orgOrthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
  100893-7 iconhttp://loinc.orgOrthopoxvirus IgG and IgM Ab panel - Serum or Plasma
  100894-5 iconhttp://loinc.orgRecommended screening frequency Narrative
  100895-2 iconhttp://loinc.orgRickettsia conorii IgG and IgM [Interpretation] in Serum
  100896-0 iconhttp://loinc.orgVasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge
  100897-8 iconhttp://loinc.orgStaphylococcus aureus [Presence] in Specimen by Organism specific culture
  100898-6 iconhttp://loinc.orgLipid panel - Serum or Plasma
  100899-4 iconhttp://loinc.orgEnterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture

Additional Language Displays

CodeDeutsch (Österreich) (German (Austria), de)Deutsch (Deutschland) (German (Germany), de)English (United States) (English (United States), en)Spanish (Argentina) (es)Spanish (es)French (France) (fr)Nederlands (Nederland) (Dutch (Netherlands), nl)Portuguese (Brazil) (pt)
100000-9Health Info Pioneer+Father of LOINC
100001-7Health Info Pioneer+Cofound LOINC
100002-5Specimen care is maintained
100003-3Team communication is maintained throughout care
100004-1Demonstrates knowledge of the expected psychosocial responses to the procedure
100005-8Demonstrates knowledge of nutritional management related to the procedure
100006-6Demonstrates knowledge of medication management
100007-4Demonstrates knowledge of pain management
10000-8R wave dur L-AVRduración de la onda R.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-AVR
100008-2Demonstrates knowledge of wound management
100009-0Demonstrates knowledge of the procedure and expected results
100010-8No injury related to procedure equipment, medical supplies, or instrumentation
100011-6No injury related to an electrical source
100012-4Participates in decisions affecting the patient's plan of care
100013-2Participates in the discharge process
100014-0Psychosocial health is maintained at or improved from baseline
100015-7No injury related to positioning due to care or procedure
10001-6R wave dur L-Iduración de la onda R.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-I
100016-5No injury related to a laser source
100017-3Perioperative nursing data set outcomes panel [PNDS]
100018-1Hospice care NoteVerslag [bevinding] in {instelling} d.m.v. hospicezorg (document)
100019-9ALK gene targeted mutation analysis, Blood or tissue specimenALK gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireALK-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100020-7GNA11 gene targeted mutation analysis, Blood or tissue specimenGNA11 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireGNA11-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100021-5GNAQ gene targeted mutation analysis, Blood or tissue specimenGNAQ gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireGNAQ-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100022-3IDH1 gene targeted mutation analysis, Blood or tissue specimenIDH1 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireIDH1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100023-1IDH2 gene targeted mutation analysis, Blood or tissue specimenIDH2 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireIDH2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
10002-4R wave dur L-IIduración de la onda R.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-II
100024-9SETBP1 gene targeted mutation analysis, Blood or tissue specimenSETBP1 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireSETBP1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100025-6SRSF2 gene targeted mutation analysis, Blood or tissue specimenSRSF2 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireSRSF2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100026-4MET gene targeted mutation analysis, Blood or tissue specimenMET gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireMET-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100027-2SMAD4 gene targeted mutation analysis, Blood or tissue specimenSMAD4 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireSMAD4-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100028-0FBXW7 gene targeted mutation analysis, Blood or tissue specimenFBXW7 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaireFBXW7-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100029-8Cancer related multigene analysis (cfDNA)Analyse multigénique en relation avec le cancer [Recherche] Plasma avec ADN libre circulant ; Document ; Biologie moléculaireKankergerelateerde multigen-analyse [bevinding] in plasma.celvrij DNA d.m.v. moleculair genetisch onderzoek (document)
100030-6Axis I: Temporal aspects score [Mainz Pain Staging System]
100031-4Axis II: Spatial aspects score [Mainz Pain Staging System]
10003-2R wave dur L-IIIduración de la onda R.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R. derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-III
100032-2Axis III: Drug taking behavior score [Mainz Pain Staging System]
100033-0Axis IV: Utilization of the health care system score [Mainz Pain Staging System]
100034-8Provider of AED
100035-5Exam finding location Chest
100036-3Exam finding location Lung
100037-1Patient contact disposition EMS unit
100038-9Patient eval disposition EMS unit
100039-7Crew disposition EMS unit
10004-0R wave dur L-V1duración de la onda R.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-V1
100040-5Pt transport disposition EMS unit
100041-3Aminoglycosid-EmpfindlichkeitAminoglycosid [Empfindlichkeit]Susceptibility to AminoglycosideAminoglycoside [Sensibilité] Isolat ; Alphanumérique
100042-1Atovaquon-EmpfindlichkeitSusceptibility to AtovaquoneAtovaquone [Sensibilité] Isolat ; AlphanumériqueAtovaquone [gevoeligheid] in isolaat
100043-9Azithromycin/Ethambutol-EmpfindlichkeitAzithromycin+Ethambutol [Empfindlichkeit]Susceptibility to Azithromycin+EthambutolAzithromycine+éthambutol [Sensibilité] Isolat ; AlphanumériqueAzitromycine + ethambutol [gevoeligheid] in isolaat
100044-7Cefcapene-EmpfindlichkeitCefcapen [Empfindlichkeit]Susceptibility to CefcapeneCefcapene [Sensibilité] Isolat ; AlphanumériqueCefcapeen [gevoeligheid] in isolaat
100045-4Cefozopran-EmpfindlichkeitSusceptibility to CefozopranCéfozopran [Sensibilité] Isolat ; AlphanumériqueCefozopran [gevoeligheid] in isolaat
100046-2Cefquinom-EmpfindlichkeitSusceptibility to CefquinomeCefquinome [Sensibilité] Isolat ; AlphanumériqueCefquinome [gevoeligheid] in isolaat
100047-0Cefteram-EmpfindlichkeitSusceptibility to CefteramCefteram [Sensibilité] Isolat ; AlphanumériqueCefteram [gevoeligheid] in isolaat
100048-8Clarithromycin/Ethambutol-EmpfindlichkeitClarithromycin+Ethambutol [Empfindlichkeit]Susceptibility to Clarithromycin+EthambutolClarithromycine+éthambutol [Sensibilité] Isolat ; AlphanumériqueClarithromycine + ethambutol [gevoeligheid] in isolaat
100049-6Eravacycline-EmpfindlichkeitEravacyclin [Empfindlichkeit]Susceptibility to EravacyclineÉravacycline [Sensibilité] Isolat ; AlphanumériqueEravacycline [gevoeligheid] in isolaat
100050-4Erythromycin/Ethambutol-EmpfindlichkeitErythromycin+Ethambutol [Empfindlichkeit]Susceptibility to Erythromycin+EthambutolÉrythromycine+éthambutol [Sensibilité] Isolat ; AlphanumériqueErytromycine + ethambutol [gevoeligheid] in isolaat
100051-2Ethambutol/rifAMPin-EmpfindlichkeitEthambutol+Rifampicin [Empfindlichkeit]Susceptibility to Ethambutol+rifAMPinÉthambutol+rifampicine [Sensibilité] Isolat ; AlphanumériqueEthambutol + rifampicine [gevoeligheid] in isolaat
100052-0Flomoxef-EmpfindlichkeitFlomoxef [Empfindlichkeit]Susceptibility to FlomoxefFlomoxef [Sensibilité] Isolat ; AlphanumériqueFlomoxef [gevoeligheid] in isolaat
100053-8Fluoroquinolon-EmpfindlichkeitFluorchinolon [Empfindlichkeit]Susceptibility to FluoroquinoloneFluoroquinolone [Sensibilité] Isolat ; AlphanumériqueFluorchinolon [gevoeligheid] in isolaat
100054-6Gamithromycin-EmpfindlichkeitSusceptibility to GamithromycinGamithromycine [Sensibilité] Isolat ; Alphanumérique
100055-3Optochin-EmpfindlichkeitOptochin [Empfindlichkeit]Susceptibility to OptochinOptochine [Sensibilité] Isolat ; AlphanumériqueOptochine [gevoeligheid] in isolaat
100056-1Panipenem-EmpfindlichkeitPanipenem [Empfindlichkeit]Susceptibility to PanipenemPanipénème [Sensibilité] Isolat ; AlphanumériquePanipenem [gevoeligheid] in isolaat
10005-7R wave dur L-V2duración de la onda R.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-V2
100057-9Prothionamid-EmpfindlichkeitProthionamid [Empfindlichkeit]Susceptibility to ProthionamideProtionamide [Sensibilité] Isolat ; AlphanumériqueProthionamide [gevoeligheid] in isolaat
100058-7Prulifloxacin-EmpfindlichkeitPrulifloxacin [Empfindlichkeit]Susceptibility to PrulifloxacinPrulifloxacine [Sensibilité] Isolat ; AlphanumériquePrulifloxacine [gevoeligheid] in isolaat
100059-5Rifapentin-EmpfindlichkeitRifapentin [Empfindlichkeit]Susceptibility to RifapentineRifapentine [Sensibilité] Isolat ; AlphanumériqueRifapentine [gevoeligheid] in isolaat
100060-3Tildipirosin-EmpfindlichkeitSusceptibility to TildipirosinTildipirosine [Sensibilité] Isolat ; Alphanumérique
100061-1Tosufloxacin-EmpfindlichkeitTosufloxacin [Empfindlichkeit]Susceptibility to TosufloxacinTosufloxacine [Sensibilité] Isolat ; AlphanumériqueTosufloxacine [gevoeligheid] in isolaat
100062-9SDOM panel
100063-7Primary skin concern
100064-5Itch severity RptPeriod Reported
10006-5R wave dur L-V3duración de la onda R.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R. derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-V3
100065-2Satisfied with treatment
100066-0Specular microscopy panelEndotheelcelmicroscopie panel in oog d.m.v. endotheelcelmicroscopie
100067-8Eye Image magnification
100068-6R eye Fixation point [Angle]
100069-4L eye Fixation point [Angle]
100070-2R cornea Cell density
100071-0L cornea Cell density
100072-8R cornea Coefficient of variation
10007-3R wave dur L-V4duración de la onda R.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R. derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-V4
100073-6L cornea Coefficient of variation
100074-4R cornea Hexagonality
100075-1L cornea Hexagonality
100076-9R cornea Endothelial cells counted
100077-7L cornea Endothelial cells counted
100078-5R cornea Endothelial cell area.min
100079-3L cornea Endothelial cell area.min
100080-1R cornea Endothelial cell area.max
10008-1R wave dur L-V5duración de la onda R.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-V5
100081-9L cornea Endothelial cell area.max
100082-7R cornea Endothelial cell area.mean
100083-5L cornea Endothelial cell area.mean
100084-3R cornea Cell area.sd
100085-0L cornea Cell area.sd
100086-8R cornea Analysis method
100087-6Toxocara canis 24-35kD IgG antibody, BloodToxocara canis 24-35kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotToxocara canis 24-35kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100088-4Taenia solium larva Ab bands panel, BloodTaenia solium cysticerque Ac bandes panel [-] Sérum ; - ; ImmunoblotTaenia solium larve As banden panel in serum d.m.v. immunoblotting
100089-2Taenia solium larva 6-8kD antibody, BloodTaenia solium cysticerque 6-8kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotTaenia solium larve 6-8kD As [aanwezigheid] in serum d.m.v. immunoblotting
1000-9DBG antibody, Blood Product Unit[anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma^unidad de hemoderivado:ordinal:DBG Ab: Suero o plasma Unidad de hemoderivado: Punto temporal: Presencia o umbral: Ordinal:DBG As [aanwezigheid] in serum of plasma^bloedproducteenheidDBG Ac SerPl BPU Ql
100090-0Taenia solium larva 45kD antibody, BloodTaenia solium cysticerque 45kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotTaenia solium larve 45kD As [aanwezigheid] in serum d.m.v. immunoblotting
100091-8Trypanosoma cruzi antibody, BloodTrypanosoma cruzi Ac [Arbitraire/Volume] Sérum ; Numérique ; ImmunoanalyseTrypanosoma cruzi As [eenheid/volume] in serum d.m.v. immunoassay
100092-6Trypanosoma cruzi Ab bands panel, BloodTrypanosoma cruzi Ac bandes panel [-] Sérum ; - ; ImmunoblotTrypanosoma cruzi As banden panel in serum d.m.v. immunoblotting
100093-4Trypanosoma cruzi 15-16kD IgG antibody, BloodTrypanosoma cruzi 15-16kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotTrypanosoma cruzi 15-16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100094-2Trypanosoma cruzi 21-22kD IgG antibody, BloodTrypanosoma cruzi 21-22kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotTrypanosoma cruzi 21-22kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100095-9Trypanosoma cruzi 27-28kD IgG antibody, BloodTrypanosoma cruzi 27-28kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotTrypanosoma cruzi 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100096-7Trypanosoma cruzi 42kD IgG antibody, BloodTrypanosoma cruzi 42kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotTrypanosoma cruzi 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100097-5Trypanosoma cruzi 45-47kD IgG antibody, BloodTrypanosoma cruzi 45-47kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotTrypanosoma cruzi 45-47kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100098-3Trypanosoma cruzi 120-200kD IgG antibody, BloodTrypanosoma cruzi 120-200kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotTrypanosoma cruzi 120-200kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
10009-9R wave dur L-V6duración de la onda R.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR onda dur L-V6
100099-1Trypanosoma cruzi 160kD IgG antibody, BloodTrypanosoma cruzi 160kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotTrypanosoma cruzi 160kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100100-7Fasciola sp IgG antibody, BloodFasciola Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoanalyseFasciola sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay
100101-5Fasciola sp 8-9kD IgG antibody, BloodFasciola 8-9kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotFasciola sp. 8-9kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100102-3Fasciola sp 27-28kD IgG antibody, BloodFasciola 27-28kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotFasciola sp. 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100103-1Fasciola sp 60kD IgG antibody, BloodFasciola 60kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotFasciola sp. 60kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100104-9Fasciola sp 42kD IgG antibody, BloodFasciola 42kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotFasciola sp. 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100105-6Filaria IgG and IgM panel, BloodFilaria Ac IgG et IgM panel [-] Sérum ; -Filaria As.IgG & IgM panel in serum
100106-4Filaria IgG antibody, BloodFilaria Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoanalyseFilaria As.IgG [aanwezigheid] in serum d.m.v. immunoassay
10010-7R' wave Amp L-AVFamplitud de la onda R'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-AVF
100107-2Leishmania sp IgG antibody, BloodLeishmania Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoanalyseLeishmania sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay
100108-0Leishmania sp IgG antibody, BloodLeishmania Ac IgG [Arbitraire/Volume] Sérum ; Numérique ; ImmunoanalyseLeishmania sp. As.IgG [eenheid/volume] in serum d.m.v. immunoassay
100109-8Leishmania sp Ab bands panel, BloodLeishmania Ac bandes panel [-] Sérum ; - ; ImmunoblotLeishmania sp. As banden panel in serum d.m.v. immunoblotting
100110-6Leishmania sp 14kD IgG antibody, BloodLeishmania 14 kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotLeishmania sp. 14kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100111-4Leishmania sp 16kD IgG antibody, BloodLeishmania 16 kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotLeishmania sp. 16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting
100112-2Fasciola sp Ab bands panel, BloodFasciola Ac bandes panel [-] Sérum ; - ; ImmunoblotFasciola sp. As-banden panel in serum d.m.v. immunoblotting
100113-0Helicobacter pylori Ab panel, BloodHelicobacter pylori Ac panel [-] Sérum ; -Helicobacter pylori As panel in serum
100114-8Toxoplasma gondii 30kD antibody, BloodToxoplasma gondii 30kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotToxoplasma gondii 30kD As [aanwezigheid] in serum d.m.v. immunoblotting
10011-5R' wave Amp L-AVLamplitud de la onda R'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-AVL
100115-5Toxoplasma gondii 31kD antibody, BloodToxoplasma gondii 31kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotToxoplasma gondii 31kD As [aanwezigheid] in serum d.m.v. immunoblotting
100116-3Toxoplasma gondii 33kD antibody, BloodToxoplasma gondii 33kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotToxoplasma gondii 33kD As [aanwezigheid] in serum d.m.v. immunoblotting
100117-1Toxoplasma gondii 40kD antibody, BloodToxoplasma gondii 40kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotToxoplasma gondii 40kD As [aanwezigheid] in serum d.m.v. immunoblotting
100118-9Toxoplasma gondii 41kD antibody, BloodToxoplasma gondii 41kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotToxoplasma gondii 41kD As [aanwezigheid] in serum d.m.v. immunoblotting
100119-7Toxoplasma gondii 45kD antibody, BloodToxoplasma gondii 45kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotToxoplasma gondii 45kD As [aanwezigheid] in serum d.m.v. immunoblotting
100120-5Chlamydia trachomatis Ab panel, BloodChlamydia trachomatis Ac panel [-] Sérum ; -Chlamydia trachomatis As panel in serum
100121-3Chlamydia trachomatis IgA-Antikörper [Nachweis] in Serum mittels ImmunoassayChlamydia trachomatis IgA antibody, BloodChlamydia trachomatis Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; ImmunoanalyseChlamydia trachomatis As.IgA [aanwezigheid] in serum d.m.v. immunoassay
100122-1C. pneumoniae Ab panel, BloodChlamydia pneumoniae Ac panel [-] Sérum ; -Chlamydophila pneumoniae As panel in serum
10012-3R' wave Amp L-AVRamplitud de la onda R'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'plomo AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-AVR
100123-9Chlamydophila pneumoniae IgA antibody, BloodChlamydia pneumoniae Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; ImmunoanalyseChlamydophila pneumoniae As.IgA [aanwezigheid] in serum d.m.v. immunoassay
100124-7Chlamydophila pneumoniae IgA antibody, BloodChlamydia pneumoniae Ac IgA [Arbitraire/Volume] Sérum ; Numérique ; ImmunoanalyseChlamydophila pneumoniae As.IgA [eenheid/volume] in serum d.m.v. immunoassay
100125-4C. psittaci Ab panel, BloodChlamydia psittaci Ac panel [-] Sérum ; -Chlamydophila psittaci As panel in serum
100126-2Bordetella pertussis Ab.IgG panel, BloodBordetella pertussis Ac IgG panel [-] Sérum ; -Bordetella pertussis As.IgG panel in serum
100127-0Campylobacter sp Ab panel, BloodCampylobacter Ac panel [-] Sérum ; -Campylobacter sp. As panel in serum
100128-8Cryptococcus sp Ag panel, BloodCryptococcus Ag panel [-] Sérum ; -Cryptococcus sp. Ag panel in serum
100129-6Schistosoma sp antibody, BloodSchistosoma Ac [Titre] Sérum ; Numérique ; HémagglutinationSchistosoma sp. As [titer] in serum d.m.v. hemagglutinatie
100130-4Schistosoma mansoni antibody, BloodSchistosoma mansoni Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma mansoni As [aanwezigheid] in serum d.m.v. immunoblotting
10013-1R' wave Amp L-Iamplitud de la onda R'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de la onda R '. I:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-I
100131-2Schistosoma sp 8kD antibody, BloodSchistosoma 8kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 8kD As [aanwezigheid] in serum d.m.v. immunoblotting
100132-0Schistosoma sp 9kD antibody, BloodSchistosoma 9kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 9kD As [aanwezigheid] in serum d.m.v. immunoblotting
100133-8Schistosoma sp 10kD antibody, BloodSchistosoma 10kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 10kD As [aanwezigheid] in serum d.m.v. immunoblotting
100134-6Schistosoma sp 11kD antibody, BloodSchistosoma 11kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 11kD As [aanwezigheid] in serum d.m.v. immunoblotting
100135-3Schistosoma sp 12-13kD antibody, BloodSchistosoma 12-13kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 12-13kD As [aanwezigheid] in serum d.m.v. immunoblotting
100136-1Schistosoma sp 14-15kD antibody, BloodSchistosoma 14-15kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 14-15kD As [aanwezigheid] in serum d.m.v. immunoblotting
100137-9Schistosoma sp 15-16kD antibody, BloodSchistosoma 15-16kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 15-16kD As [aanwezigheid] in serum d.m.v. immunoblotting
100138-7Schistosoma sp 18-19kD antibody, BloodSchistosoma 18-19kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 18-19kD As [aanwezigheid] in serum d.m.v. immunoblotting
100139-5Schistosoma sp 22-24kD antibody, BloodSchistosoma 22-24kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 22-24kD As [aanwezigheid] in serum d.m.v. immunoblotting
100140-3Schistosoma sp 30-34kD antibody, BloodSchistosoma 30-34kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 30-34kD As [aanwezigheid] in serum d.m.v. immunoblotting
100141-1Schistosoma sp 65kD antibody, BloodSchistosoma 65kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 65kD As [aanwezigheid] in serum d.m.v. immunoblotting
100142-9Schistosoma sp 70kD antibody, BloodSchistosoma 70kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 70kD As [aanwezigheid] in serum d.m.v. immunoblotting
100143-7Schistosoma sp 80kD antibody, BloodSchistosoma 80kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 80kD As [aanwezigheid] in serum d.m.v. immunoblotting
100144-5Schistosoma sp 95kD antibody, BloodSchistosoma 95kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 95kD As [aanwezigheid] in serum d.m.v. immunoblotting
100145-2Schistosoma sp 110kD antibody, BloodSchistosoma 110kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 110kD As [aanwezigheid] in serum d.m.v. immunoblotting
100146-0Schistosoma sp 120kD antibody, BloodSchistosoma 120kD Ac [Présence/Seuil] Sérum ; Qualitatif ; ImmunoblotSchistosoma sp. 120kD As [aanwezigheid] in serum d.m.v. immunoblotting
100147-8Toxoplasma gondii Ab bands panel, BloodToxoplasma gondii Ac bandes panel [-] Sérum ; - ; ImmunoblotToxoplasma gondii As banden panel in serum d.m.v. immunoblotting
100148-6Schistosoma sp Ab bands panel, BloodSchistosoma Ac bandes panel [-] Sérum ; - ; ImmunoblotSchistosoma sp. As banden panel in serum d.m.v. immunoblotting
10014-9R' wave Amp L-IIamplitud de la onda R'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-II
100149-46-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel, Urine+Blood6-oxo-pipéridine-2-carboxylate et 6(R+S)-oxo-propylpipéridine-2-carboxylate panel [-] Urine+Sérum/Plasma ; -6-oxo-piperidine-2-carboxylaat & 6(R+S)-oxo-propylpiperidine-2-carboxylaat in urine en serum of plasma
100150-26(R+S)-oxo-propylpiperidine-2-carboxylate, Blood6(R+S)-oxo-propylpipéridine-2-carboxylate [Moles/Volume] Plasma ; Numérique6(R+S)-oxo-propylpiperidine-2-carboxylaat [mol/volume] in plasma
100151-06-oxo-piperidine-2-carboxylate, Blood6-oxo-pipéridine-2-carboxylate [Moles/Volume] Plasma ; Numérique6-oxo-piperidine-2-carboxylaat [mol/volume] in plasma
100152-86-oxo-piperidine-2-carboxylate/Creatinine, Urine6-oxo-pipéridine-2-carboxylate/créatinine [Moles ratio] Urine ; Numérique6-oxo-piperidine-2-carboxylaat/creatinine [molaire verhouding] in urine
100153-66(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine, Urine6(R+S)-oxo-propylpipéridine-2-carboxylate/créatinine [Moles ratio] Urine ; Numérique6(R+S)-oxo-propylpiperidine-2-carboxylaat/creatinine [molaire verhouding] in urine
100154-4Collection supervision level, SpecimenNiveau de supervision du recueil [Recherche] Prélèvement ; Résultat nominal
100155-1L cornea Analysis method
10015-6R' wave Amp L-IIIamplitud de la onda R'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-III
100156-9SARS-CoV-2 (COVID-19)-Variante [Typ] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionSARS-CoV-2 (COVID-19) variant, SpecimenCoronavirus SARS-CoV-2 variant [Type] Milieux divers ; Résultat nominal ; PCR amplification de cibleSARS-CoV-2-variant [type] d.m.v. probe-detectie
100157-7SARS-CoV-2 (COVID-19)-Abstammungslinie [Typ] in Probenmaterial mittels SequenzierungSARS-CoV-2 (COVID-19) lineage, SpecimenCoronavirus SARS-CoV-2 lignée [Type] Milieux divers ; Résultat nominal ; SéquençageSARS-CoV-2 lineage [type] d.m.v. sequencing
100158-5Albumin, UrineAlbumine [Masse/Volume] Temps non précisé ; Urine ; Numérique ; Limite de détection<=20mg/LAlbumine [massa/volume] in urine (verzamelduur niet gespecificeerd) d.m.v. detectielimiet <= 20 mg/L
100159-3Knee Society Score pre-op panel [Knee Society Score]
100160-1Knee replacement
100161-9Charnley Functional Classification
100162-7Alignment W Stand Knee XR
100163-5Knee medial AndOr lateral instability W full extension
10016-4R' wave Amp L-V1amplitud de la onda R'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-V1
100164-3Knee AP instability W 90 degree flexion
100165-0Knee Qn
100166-8Flexion contracture range Knee
100167-6Extensor lag range Knee
100168-4Knee pain severity with level walking
100169-2Knee pain severity with stairs or inclines
1001-7DBG antibody, Donor Blood[anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:relación suero/plasma^donante:ordinal:DBG Ab: Suero o plasma Donante: Punto temporal: Presencia o umbral: Ordinal:DBG As [aanwezigheid] in serum of plasma^donorDBG Ac SerPl Donr Ql
100170-0Knee feels normal
100171-8Satisfaction with level of knee pain while sitting
10017-2R' wave Amp L-V2amplitud de la onda R'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-V2
100172-6Satisfaction with level of knee pain while lying in bed
100173-4Satisfaction with knee function while getting out of bed
100174-2Satisfaction with knee function while performing light household duties
100175-9Satisfaction with knee function while performing recreational activities
100176-7Expect surgery to relieve pain
100177-5Expect surgery will improve ability to perform activities of daily living
100178-3Expect surgery will improve ability to perform leisure, recreational, or sports activities
100179-1Walk without assistive mobility devices
10018-0R' wave Amp L-V3amplitud de la onda R'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-V3
100180-9Assistive mobility devices used
100181-7Assistive mobility devices used due to health condition
100182-5Duration of standing before sitting due to knee discomfort
100183-3Duration of walking before stopping due to knee discomfort
100184-1How bothersome is knee when walking on an uneven surface
100185-8How bothersome is knee when turning or pivoting leg
100186-6How bothersome is knee when climbing up or down a flight of stairs
100187-4How bothersome is knee when getting up from a low seat without armrests
100188-2How bothersome is knee when getting into or out of a car
100189-0How bothersome is knee when moving laterally
100190-8How bothersome is knee when climbing a ladder or step stool
100191-6How bothersome is knee when carrying a bag for one block
100192-4How bothersome is knee when squatting
100193-2How bothersome is knee when kneeling
100194-0How bothersome is knee when running
100195-7Pain severity--during activity
100196-5Pre-op total score [Knee Society Score]
100197-3Exercise activity and pain severity panel
10019-8R' wave Amp L-V4amplitud de la onda R'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-V4
100198-1Pre-op objective knee indicators score [Knee Society Score]
100199-9Pre-op symptoms score [Knee Society Score]
100200-5Pre-op patient expectations score [Knee Society Score]
100201-3Pre-op functional activities score [Knee Society Score]
100202-1Pre-op discretionary knee activities score [Knee Society Score]
100203-9Knee Society Score post-op panel [Knee Society Score]
100204-7Accuracy of pre-surgery expectations of pain relief
100205-4Accuracy of pre-surgery expectations to perform activities of daily living
10020-6R' wave Amp L-V5amplitud de la onda R'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-V5
100206-2Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities
100207-0Post-op total score [Knee Society Score]
100208-8Post-op objective knee indicators score [Knee Society Score]
100209-6Post-op symptoms score [Knee Society Score]
100210-4Post-op patient expectations score [Knee Society Score]
100211-2Post-op functional activities score [Knee Society Score]
100212-0Post-op discretionary knee activities score [Knee Society Score]
100213-8Prostate cancer multigene analysis, Blood or tissue specimenAnalyse multigénique du cancer de la prostate [Recherche] Sang/Tissu ; Document ; Biologie moléculaireProstaatkanker multigen-analyse [bevinding] in bloed of weefsel d.m.v. moleculair genetisch onderzoek (document)
10021-4R' wave Amp L-V6amplitud de la onda R'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda R 'derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKGR' onda Amp L-V6
100214-6Dental model prior auth Doc
100215-3Episode of care med rec Doc Transpl surgVerslag van zorgepisode [bevinding] d.m.v. transplantatiechirurgie (document)
100216-1Surgical synoptic reportBeknopt rapport [bevinding] d.m.v. chirurgie (tekstueel)
100217-9Synoptic report Surg Onc
100218-7Surg onc colon CA synoptic rep
100219-5Surg onc melanoma CA synoptic rep
100220-3Surg onc breast CA synoptic rep
100221-1Surg onc thyroid CA synoptic rep
10022-2R' wave dur L-AVFduración de la onda R'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-AVF
100222-9Surg onc pancreas CA synoptic rep
100223-7Retina Phys find
100224-5Cardiac LV SWM Pnl LV US
100225-2Bone density QUS
100226-0Sm bowel capsule endo study Doc
100227-8Colon capsule endo study Doc
100228-6UGI capsule endo study Doc
100229-4Endo US study Doc
10023-0R' wave dur L-AVLduración de la onda R'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-AVL
100230-2Routine prenatal pnl
100231-0EBUS study
100232-8Impacts of Events Scale-Revised panel
100233-6Reminders brought back feelings about adverse event
100234-4Trouble staying asleep
100235-1Other things triggered persistent thoughts about adverse event
100236-9Felt irritable AndOr angry
100237-7Avoided getting upset when unintentionally thought about adverse event
100238-5Thought about adverse event unintentionally
100239-3Felt as if adverse event did not happen
100240-1Avoided reminders of adverse event
100241-9Experienced mental images of adverse event
100242-7Easily startled
100243-5Tried to not think of adverse event
100244-3Aware of feelings about adverse event, but did not address them
100245-0Feelings about adverse event were numb
100246-8Acted or felt the same as during adverse event
100247-6Trouble falling asleep
10024-8R' wave dur L-AVRduración de la onda R'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'plomo AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-AVR
100248-4Waves of strong feelings about adverse event
100249-2Tried to remove adverse event from memory
1002-5DBG antibody, Blood[anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal:DBG Ab: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal:DBG As [aanwezigheid] in serum of plasmaDBG Ac SerPl Ql
100250-0Trouble concentrating
100251-8Reminders of adverse event caused physical reactions
100252-6Had dreams about adverse event
100253-4Felt watchful and on-guard
100254-2Tried not to talk about adverse event
10025-5R' wave dur L-Iduración de la onda R'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R '.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-I
100255-9Total score [Impact of Event Scale-Revised]
100256-7Fallen in last 6Mo
100257-5Feel unsteady when standing or walking
100258-3History of fall related injury
100259-1Aware of tactile sensations
100260-9Easy to describe thoughts AndOr feelings
100261-7Critical of own thoughts AndOr feelings
100262-5Able to notice distressing thoughts AndOr feelings without having to react
10026-3R' wave dur L-IIduración de la onda R'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-II
100263-3Easily distracted
100264-1Able to notice thoughts AndOr feelings without being overwhelmed
100265-8Aware of dietary intake impact on self
100266-6Difficult to describe thoughts AndOr feelings
100267-4Aware of auditory stimuli
100268-2Able to avoid immediate reaction in difficult situations
100269-0Do things without paying attention
100270-8Recover quickly from distressing thoughts AndOr images
10027-1R' wave dur L-IIIduración de la onda R'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-III
100271-6Aware of olfactory stimuli
100272-4Aware of visual stimuli
100273-2Aware of emotions affect on thoughts AndOr behavior
100274-0Observing score [FFMQ]
100275-7Describing score [FFMQ]
100276-5Acting with awareness score [FFMQ]
100277-3Nonjudging score [FFMQ]
100278-1Nonreactivity score [FFMQ]
100279-9Total score [FFMQ]
100280-7Five Facet Mindfulness Questionnaire panel [FFMQ]
100281-5D antibody, BloodRH1 (D) anticorps [Arbitraire/Volume] Sérum/Plasma ; NumériqueD As [eenheid/volume] in serum of plasma
100282-3Vaccine exemption cert
100283-1Harris Hip Score panel [Harris Hip Score]
100284-9Walking - functional ability
100285-6Comfortable seated position
100286-4Able to board public transportation
100287-2Put on shoes and socks
100288-0Absence of deformity score [Harris Hip Score]
10028-9R' wave dur L-V1duración de la onda R'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-V1
100289-8Absence of hip deformity measurements
100290-6Range of motion score [Harris Hip Score]
100291-4Total score [Harris Hip Score]
100292-2Pre-op patient satisfaction score [Knee Society Score]
100293-0Hip Flexion range of motion
100294-8Hip Abduction range of motion
100295-5Hip Adduction range of motion
100296-3Hip External rotation range of motion
10029-7R' wave dur L-V2duración de la onda R'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-V2
100297-1Hip Internal rotation range of motion
100298-9Rep count
100299-7Post-op patient satisfaction score [Knee Society Score]
100300-3End time
100301-1Start time
100302-9Time start/end panel Spec
100303-7Condition certainty of presence
100304-5Flights climbed RptPeriod
10030-5R' wave dur L-V3duración de la onda R'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-V3
100305-2IDH1 gene exon 4 targeted mutation analysis, Blood Or Bone marrowIDH1 gène exon 4 mutation cible trouvée [Présence/Seuil] Sang/Moelle osseuse ; Qualitatif ; Biologie moléculaireIDH1-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek
100306-0IDH2 gene exon 4 targeted mutation analysis, Blood Or Bone marrowIDH2 gène exon 4 mutation cible trouvée [Présence/Seuil] Sang/Moelle osseuse ; Qualitatif ; Biologie moléculaireIDH2-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek
100307-8Behavioral screening elder mistreatment
100308-6Need help getting to essential places
100309-4Activity support person
100310-2Reliability of support person
100311-0Need help to make sure there is enough food, medicines or any other things needed in house
100312-8Person or persons that makes sure there is enough food, medicines or any other things needed in house
10031-3R' wave dur L-V4duración de la onda R'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-V4
100313-6Need help with household things such as cook meals, help feed, or provide correct medicines each day
100314-4Need help with house cleaning or yard work
100315-1Need help getting out of bed, showered, or dressed
100316-9Need help to make sure bills get paid
100317-7Relationship of usual support person for daily activities
100318-5Have help with finances AndOr financial decisions
100319-3Relationship of financial support person
100320-1Financial support person usually asks for permission before making decisions
10032-1R' wave dur L-V5duración de la onda R'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-V5
100321-9Financial support person usually makes good decisions about finances
100322-7Have access to paperwork for financial decisions made
100323-5Financial support person forged signature
100324-3Coercion of financial support person for signing a document in order to get money or possessions
100325-0Experienced theft by support person
100326-8Money spent or property sold without permission
100327-6Stranger forged signature for financial gain
100328-4Stranger forced document signature for financial gain
100329-2Feared for safety due to verbal attack
1003-3Indirect Antiglobulin Test (IAT; Indirect Coombs), Bloodprueba de antiglobulina indirecta.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal:Prueba de antiglobulina indirecta, reactivo específico del complemento: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal:Test indirect à l'antiglobuline (TIA) complément spécifique [Présence/Seuil] Sérum/Plasma ; QualitatifIndirecte antiglobulinetest.complement-specifiek reagent [aanwezigheid] in serum of plasmaIAT Comp-Sp Reag SerPl Ql
100330-0Felt humiliated due to ridicule
100331-8Coerced to do something
100332-6Ignored by close friend or relative for extended period
100333-4Physically hit or threatened
100334-2Been physically hurt with some degree of injury
100335-9Coerced sexual activity
100336-7Coerced touching of private body parts of self or others
100337-5Coerced to undress or expose private body area
100338-3Photographed in any degree of nudity without consent
10033-9R' wave dur L-V6duración de la onda R'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda R 'plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGR' onda dur L-V6
100339-1Experienced attempted physical restraint
100340-9Range of motion panel Hip
100341-7Rötelnvirus Antikörper-IndexRöteln-Virus IgG-Antikörperindex [Einheiten/Volumen] in Serum und LiquorRubella virus IgG index, Serum+Cerebrospinal fluidRubéole virus Ac IgG index [Arbitraire/Volume] Sérum+Liquide céphalorachidien ; NumériqueRubellavirus As.IgG-index [eenheid/volume] in serum en liquor cerebrospinalis
100342-5Flüchtige organische Verbindungen assoziiert mit SARS-CoV-2-Infektion [Nachweis] in Exhalat mittels GC-MSVolatile Organic Compounds associated with SARS-CoV-2 infection, Exhaled gasComposés organiques volatiles associés à l'infection SARS-CoV-2 [Présence/Seuil] Gaz expiré ; QualitatifVluchtige organische componenten bij SARS-CoV-2-infectie [aanwezigheid] in uitgeademde lucht d.m.v. gaschromatografie-massaspectrometrie
100343-3Influenza-Virus B RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit SondendetektionInfluenza B (Flu B), SalivaInfluenza virus B ARN [Présence/Seuil] Salive ; Qualitatif ; PCR amplification de cibleInfluenzavirus B RNA [aanwezigheid] in speeksel d.m.v. probe-detectie
100344-1Influenza-Virus A RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit SondendetektionInfluenza A (Flu A), SalivaInfluenza virus A ARN [Présence/Seuil] Salive ; Qualitatif ; PCR amplification de cibleInfluenzavirus A RNA [aanwezigheid] in speeksel d.m.v. probe-detectie
100345-8Influenza-Virus A und Influenza-Virus B und SARS-CoV-2 (COVID-19) RNA (Liste) - Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel, SpecimenInfluenza virus A et B et Coronavirus SARS-Cov-2 ARN panel [-] Milieux divers ; - ; PCR amplification de cibleInfluenzavirus A & influenzavirus B & SARS-CoV-2 RNA panel d.m.v. probe-detectie
100346-6Clotting time.extrinsic coagulation system activated.platelets inhibited, BloodTemps de coagulation (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle
10034-7S wave Amp L-AVFamplitud de la onda S.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-AVF
100347-4Clot formation.extrinsic coagulation system activated.platelets inhibited, BloodTemps de formation du caillot (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle
100348-2MELDNa score
100349-0DOP Penis ves W vasodilator IV
100350-8Sesamum indicum 1 allergy testSésame (graine) 1 Ac IgE [Arbitraire/Volume] Sérum ; NumériqueSesamum indicum 1 As.IgE [eenheid/volume] in serum
100351-6Pioglitazone, BloodPioglitazone [Présence/Seuil] Sérum/Plasma ; QualitatifPioglitazon [aanwezigheid] in serum of plasma
100352-4Rosiglitazone, BloodRosiglitazone [Présence/Seuil] Sérum/Plasma ; QualitatifRosiglitazon [aanwezigheid] in serum of plasma
100353-2Norwalk Community Health Center Screening Tool [NCHC]
10035-4S wave Amp L-AVLamplitud de la onda S.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. Conducir AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-AVL
100354-0Frequency of participating in multi-modal communication without assistance
100355-7Frequency of participating in spoken language expression communication without assistance
100356-5Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis, SpecimenChlamydia trachomatis et Neisseria gonorrhoeae et Trichomonas vaginalis ADN [Identification] Milieux divers ; Résultat nominal ; PCR amplification de cibleChlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA [identificator] d.m.v. probe-detectie
100357-3Naloxone, Umbilical cord tissueNaloxone [Présence/Seuil] Tissu de cordon ; Qualitatif ; DépistageNaloxon [aanwezigheid] in weefsel van navelstreng d.m.v. screening
100358-1Phentermine, Umbilical cord tissuePhentermine [Présence/Seuil] Tissu de cordon ; Qualitatif ; DépistageFentermine [aanwezigheid] in weefsel van navelstreng d.m.v. screening
100359-9Gliadin 33 mer peptide, StoolGliadine 33-mer peptide [Masse/Volume] Selle ; Numérique ; ImmunoanalyseGliadin 33-mer peptide [massa/volume] in feces d.m.v. immunoassay
100360-7Brief Resilience Scale panel [BRS]
100361-5Quickly recover from bad events
10036-2S wave Amp L-AVRamplitud de la onda S.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. Conducir AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-AVR
100362-3Difficulty making it through stressful events
100363-1Easily recover from a stressful event
100364-9Difficulty recovering from bad events
100365-6Easily recover from difficulties
100366-4Lengthy recovery from setbacks
100367-2Total Score BRS
100368-0Amino Acids Urea Cycle Panel, BloodAcides aminés du cycle de l'urée panel [-] Sérum/Plasma ; - ; LC/MS/MSAminozuren ureumcyclus panel in serum of plasma d.m.v. LC/MS/MS
100369-8NM Thyroid Views W Tl-201 IV
10037-0S wave Amp L-Iamplitud de la onda S.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de la onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-I
100370-6Orthopoxvirus DNA [Nachweis oder Identität] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionOrthopoxvirus, SpecimenOrthopoxvirus ADN [Identification] Milieux divers ; Résultat nominal ; PCR amplification de cibleOrthopoxvirus DNA [identificator] d.m.v. probe-detectie
100371-4Titin antibody, BloodTitine anticorps [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse
100372-2Abiraterone, BloodAbiratérone [Masse/Volume] Sérum/Plasma ; NumériqueAbirateron [massa/volume] in serum of plasma
100373-0Agar- agar IgG antibodyEucheuma Ac IgG [Arbitraire/Volume] Sérum ; NumériqueEucheuma As.IgG [eenheid/volume] in serum
100374-8Aloe vera IgG antibodyAloe vera Ac IgG [Arbitraire/Volume] Sérum ; NumériqueAloë vera As.IgG [eenheid/volume] in serum
100375-5Anise IgG antibodyAnis Ac IgG [Arbitraire/Volume] Sérum ; NumériquePimpinella anisum As.IgG [eenheid/volume] in serum
100376-3Bambusa vulgaris IgG antibodyBambou commun Ac IgG [Arbitraire/Volume] Sérum ; NumériqueBambusa vulgaris As.IgG [eenheid/volume] in serum
100377-1Goat cheese IgG antibodyFromage de chèvre Ac IgG [Arbitraire/Volume] Sérum ; NumériqueGeitenkaas As.IgG [eenheid/volume] in serum
100378-9Sheep cheese IgG antibodyFromage de brebis Ac IgG [Arbitraire/Volume] Sérum ; NumériqueSchapenkaas As.IgG [eenheid/volume] in serum
100379-7Leeks IgG antibodyPoireau vivace Ac IgG [Arbitraire/Volume] Sérum ; NumériqueAllium ampeloprasum As.IgG [eenheid/volume] in serum
100380-5Red cabbage IgG antibodyChou rouge Ac IgG [Arbitraire/Volume] Sérum ; NumériqueBrassica rubra As.IgG [eenheid/volume] in serum
100381-3Mentha balsamea Wild IgG antibodyMenthe poivrée hybride Ac IgG [Arbitraire/Volume] Sérum ; NumériquePepermunt As.IgG [eenheid/volume] in serum
100382-1FDA insert REMS addressed risk
100383-9Affenpocken-Virus DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionMonkeypox virus, SpecimenMonkeypox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cibleMpoxvirus DNA [aanwezigheid] d.m.v. probe-detectie
100384-7Rapeseed IgG antibodyChou champêtre Ac IgG [Arbitraire/Volume] Sérum ; NumériqueBrassica rapa As.IgG [eenheid/volume] in serum
100385-4Corn salad IgG antibodyMâche Ac IgG [Arbitraire/Volume] Sérum ; NumériqueValerianella locusta As.IgG [eenheid/volume] in serum
100386-2Rosemary IgG antibodyRomarin Ac IgG [Arbitraire/Volume] Sérum ; NumériqueRosmarinus officinalis As.IgG [eenheid/volume] in serum
100387-0Poppy seed IgG antibodyPavot (graine) Ac IgG [Arbitraire/Volume] Sérum ; NumériquePapaver somniferum As.IgG [eenheid/volume] in serum
10038-8S wave Amp L-IIamplitud de la onda S.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-II
100388-8Cocoa IgG antibodyCacao Ac IgG [Arbitraire/Volume] Sérum ; NumériqueTheobroma cacao As.IgG [eenheid/volume] in serum
100389-6Pistachio IgG antibodyPistache Ac IgG [Arbitraire/Volume] Sérum ; NumériquePistacia vera As.IgG [eenheid/volume] in serum
100390-4Sunflower seed IgG antibodyTournesol (graine) Ac IgG [Arbitraire/Volume] Sérum ; NumériqueHelianthus annuus zaad As.IgG [eenheid/volume] in serum
100391-2Dates IgG antibodyDatte Ac IgG [Arbitraire/Volume] Sérum ; NumériquePhoenix dactylifera As.IgG [eenheid/volume] in serum
100392-0Duck meat IgG antibodyCanard (viande) Ac IgG [Arbitraire/Volume] Sérum ; NumériqueEendenvlees As.IgG [eenheid/volume] in serum
100393-8Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG antibodyAllergène de champigons macroscopiques mix2 (Xerocomus, Boletus) Ac IgG [Arbitraire/Volume] Sérum ; NumériquePaddenstoelallergenen mix 2 (Xerocomus + Boletus) As.IgG [eenheid/volume] in serum
100394-6Decapod crustaceans IgG antibodyAstacoidea Ac IgG [Arbitraire/Volume] Sérum ; NumériqueAstacoidea As.IgG [eenheid/volume] in serum
100395-3Carob IgG antibodyCaroube Ac IgG [Arbitraire/Volume] Sérum ; NumériqueCeratonia siliqua As.IgG [eenheid/volume] in serum
10039-6S wave Amp L-IIIamplitud de la onda S.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-III
100396-1Brassica napus IgG antibodyColza Ac IgG [Arbitraire/Volume] Sérum ; NumériqueBrassica napus As.IgG [eenheid/volume] in serum
100397-9Goat Meat IgG antibodyBouquetin Ac IgG [Arbitraire/Volume] Sérum ; NumériqueGeitenvlees As.IgG [eenheid/volume] in serum
100398-7Goose meat IgG antibodyOie (viande) Ac IgG [Arbitraire/Volume] Sérum ; NumériqueGanzenvlees As.IgG [eenheid/volume] in serum
100399-5Ostrich meat IgG antibodyAutruche (viande) Ac IgG [Arbitraire/Volume] Sérum ; NumériqueStruisvogelvlees As.IgG [eenheid/volume] in serum
100400-1Quail meat IgG antibodyCaille (viande) Ac IgG [Arbitraire/Volume] Sérum ; NumériqueKwartelvlees As.IgG [eenheid/volume] in serum
100401-9Rabbit meat IgG antibodyLapin (viande) Ac IgG [Arbitraire/Volume] Sérum ; NumériqueKonijnenvlees As.IgG [eenheid/volume] in serum
100402-7Venison meat IgG antibodyVenaison (viande) Ac IgG [Arbitraire/Volume] Sérum ; NumériqueHertenvlees As.IgG [eenheid/volume] in serum
100403-5Guineafowl IgG antibodyPintade Ac IgG [Arbitraire/Volume] Sérum ; NumériqueParelhoen As.IgG [eenheid/volume] in serum
10040-4S wave Amp L-V1amplitud de la onda S.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-V1
100404-3Horse meat IgG antibodyCheval (viande) Ac IgG [Arbitraire/Volume] Sérum ; NumériquePaardenvlees As.IgG [eenheid/volume] in serum
100405-0Kefir IgG antibodyKefir Ac IgG [Arbitraire/Volume] Sérum ; NumériqueKefir As.IgG [eenheid/volume] in serum
100406-8Butter IgG antibodyBeurre Ac IgG [Arbitraire/Volume] Sérum ; NumériqueBoter As.IgG [eenheid/volume] in serum
100407-6Camembert cheese IgG antibodyFromage camembert Ac IgG [Arbitraire/Volume] Sérum ; NumériqueCamembert As.IgG [eenheid/volume] in serum
100408-4Emmental cheese IgG antibodyFromage emmental Ac IgG [Arbitraire/Volume] Sérum ; NumériqueEmmentaler kaas As.IgG [eenheid/volume] in serum
100409-2Processed cheese IgG antibodyFromage fondu Ac IgG [Arbitraire/Volume] Sérum ; NumériqueSmeltkaas As.IgG [eenheid/volume] in serum
1004-1Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cellsprueba de antiglobulina directa.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal:Test de antiglobulina directo, reactivo específico del complemento: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal:Test direct à l'antiglobuline (EDA) complément spécifique [Présence/Seuil] Érythrocytes ; QualitatifDirecte antiglobulinetest.complement specifiek reagens [aanwezigheid] in erytrocytenDAT Comp-Sp Reag RBC Ql
100410-0Curd cheese IgG antibodyFromage blanc Ac IgG [Arbitraire/Volume] Sérum ; NumériqueKwark As.IgG [eenheid/volume] in serum
100411-8Sugar beet IgG antibodyBetterave sucrière Ac IgG [Arbitraire/Volume] Sérum ; NumériqueBèta-vulgaris As.IgG [eenheid/volume] in serum
10041-2S wave Amp L-V2amplitud de la onda S.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-V2
100412-6Chinese cabbage IgG antibodyChou chinois Ac IgG [Arbitraire/Volume] Sérum ; NumériqueChinese kool As.IgG [eenheid/volume] in serum
100413-4Fennel fresh IgG antibodyFenouil Ac IgG [Arbitraire/Volume] Sérum ; NumériqueFoeniculum vulgare vers As.IgG [eenheid/volume] in serum
100414-2Gourd IgG antibodyCucurbitaceae Ac IgG [Arbitraire/Volume] Sérum ; NumériqueGenera in Cucurbitaceae As.IgG [eenheid/volume] in serum
100415-9Kale IgG antibodyChou frisé Ac IgG [Arbitraire/Volume] Sérum ; NumériqueBrassica oleracea var. Borecole As.IgG [eenheid/volume] in serum
100416-7Savoy cabbage IgG antibodyChou de Milan [Arbitraire/Volume] Sérum ; NumériqueBrassica oleracea var. Sabauda As.IgG [eenheid/volume] in serum
100417-5Vitis sp leaf IgG antibodyFeuille de vigne Ac IgG [Arbitraire/Volume] Sérum ; NumériqueBlad van Vitis sp. As.IgG [eenheid/volume] in serum
100418-3Liquorice IgG antibodyRéglisse Ac IgG [Arbitraire/Volume] Sérum ; NumériqueGlycyrrhiza glabra As.IgG [eenheid/volume] in serum
100419-1Snow pea IgG antibodyPois gourmand Ac IgG [Arbitraire/Volume] Sérum ; NumériquePisum sativum var. saccharatum As.IgG [eenheid/volume] in serum
10042-0S wave Amp L-V3amplitud de la onda S.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-V3
100420-9Fava bean IgG antibodyFève Ac IgG [Arbitraire/Volume] Sérum ; NumériqueVicia faba As.IgG [eenheid/volume] in serum
100421-7Chick pea IgG antibodyPois chiche Ac IgG [Arbitraire/Volume] Sérum ; NumériqueCicer arietinus As.IgG [eenheid/volume] in serum
100422-5Chicory IgG antibodyChicorée sauvage Ac IgG [Arbitraire/Volume] Sérum ; NumériqueCichorium intybus As.IgG [eenheid/volume] in serum
100423-3Button + oyster + Shiitaki + chanterelle mushroom IgG antibody(Champignon de Paris+pleurote+lentin du chêne+catharelle) Ac IgG [Arbitraire/Volume] Sérum ; NumériquePaddenstoelallergenen mix 1 (Agaricus bisporus + Pleurotus ostreatus + Lentinula edodes + Cantharellus) As.IgG [eenheid/volume] in serum
100424-18(9)-Cholestenol, Blood8(9)-cholesténol [Masse/Volume] Sérum/Plasma ; Numérique8(9)-cholestenol [massa/volume] in serum of plasma
100425-8DiHydro T-Mas, BloodDihydro T-Mas [Masse/Volume] Sérum/Plasma ; NumériqueDiHydro T-Mas [massa/volume] in serum of plasma
100426-6Squalene, BloodSqualène [Masse/Volume] Sérum/Plasma ; Numérique
100427-4Stigmasterol, BloodStigmastérol [Masse/Volume] Sérum/Plasma ; NumériqueStigmasterol [massa/volume] in serum of plasma
100428-2Carnitine free and total and acylcarnitine panel, UrineCarnitine libre et totale et acylcarnitine panel [-] Urine ; -Carnitine.vrij & totaal & acylcarnitine panel in urine
100429-0LRBA deficiency panel, BloodDéficience protéine LRBA panel [-] Sang ; -LRBA-deficiëntie panel in bloed
100430-8Cells.LRBA+ 100 Cells.CD3+CD14-CD45+, BloodLRBA+/100 cellules CD3+CD14-CD45+ [Fraction de nombres] Sang ; Numérique ; Cytométrie de fluxCellen.LRBA+/100 cellen.CD3+CD14-CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie
100431-6T-cells LRBA MFI, BloodCD3+CD14-CD45+LRBA intensité de fluorescence [Arbitraire] Sang ; Numérique ; Cytométrie de fluxCellen.CD3+CD14-CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie
100432-4Cells.LRBA+ 100 Cells.CD3-CD14-CD19+CD45+, BloodLRBA+/100 cellules CD3-CD14-CD19+CD45+ [Fraction de nombres] Sang ; Numérique ; Cytométrie de fluxCellen.LRBA+/100 cellen.CD3-CD14-CD19+CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie
100433-2B-cells LRBA MFI, BloodCD3-CD14-CD19+CD45+LRBA intensité de fluorescence [Arbitraire] Sang ; Numérique ; Cytométrie de fluxCellen.CD3-CD14-CD19+CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie
100434-0Orthopoxvirus.nicht-variola DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionOrthopoxvirus.non-variola, SpecimenOrthopoxvirus non variola ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cibleOrthopoxvirus anders dan variolavirus DNA [aanwezigheid] d.m.v. probe-detectie
100435-7Glial fibrillary acidic protein, BloodGFAP [Masse/Volume] Sérum ; Numérique ; ImmunoanalyseGliaal fibrillair acidisch proteïne [massa/volume] in serum d.m.v. immunoassay
100436-5Ubiquitin carboxyl-terminal hydrolase-L1, BloodUbiquitin carboxyl-terminal hydrolase-L1 [Masse/Volume] Sérum ; Numérique ; Immunoanalyse
100437-3Norsufentanil, UrineNorsufentanil [Masse/Volume] Urine ; Numérique ; ConfirmationNorsufentanil [massa/volume] in urine d.m.v. bevestiging
10043-8S wave Amp L-V4amplitud de la onda S.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-V4
100438-1Adolescent med OP Prog note
100439-9Allergy+Immunology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. allergie+immunologie (document)
100440-7Allergy OP Prog note
100441-5Attend OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. behandelend arts (document)
100442-3Audiology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. audiologie (document)
100443-1Bariatric surg OP Prog note
100444-9Bld Bnk+Trans Med OP Prog note
100445-6BM Transplant OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. beenmergtransplantatie (document)
10044-6S wave Amp L-V5amplitud de la onda S.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-V5
100446-4Breastfeeding OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. borstvoeding (document)
100447-2Burn OP Prog note
100448-0Cardiac surgery OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. cardiochirurgie (document)
100449-8Cardio+Pulm disease OP Prog note
100450-6Child+teen psych OP Prog note
100451-4Chiropractic med OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. chiropractie (document)
100452-2Electrophysiology OP Prog note
10045-3S wave Amp L-V6amplitud de la onda S.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS onda Amp L-V6
100453-0Clinical genetics OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. klinische genetica (document)
100454-8Clinical Neurophys OP Prog note
100455-5Clin Path OP Prog note
100456-3Col+rec surg OP Prog note
100457-1Consultant OP Prog note
100458-9OP COVID-19 Intub+Progress
100459-7OP COVID-19 Progress note
100460-5Dermatology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. dermatologie (document)
10046-1S wave dur L-AVFduración de la onda S.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-AVF
100461-3Develop-behav peds OP Prog note
100462-1Dialy+Ther Apher OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. dialyse en therapeutische aferese (document)
100463-9Eating disorders OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. eetstoornis (document)
100464-7Endocrinology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. endocrinologie (document)
100465-4Fam Med OP Prog note
100466-2Gastroenterology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. gastro-enterologie (document)
100467-0Geri med OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. geriatrie (document)
100468-8Gyn Onc OP Prog note
100469-6Gynecology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. gynaecologie (document)
100470-4Navigator OP Prog note
100471-2Heart failure OP Prog note
100472-0HF+TC OP Prog note
100473-8Hematology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie (document)
100474-6HemOnc OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie + oncologie (document)
100475-3Hepatology OP Prog note
100476-1Immunology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. immunologie (document)
100477-9Infectious disease OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. infectioloog (document)
100478-7Internal Med OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. interne geneeskunde (document)
10047-9S wave dur L-AVLduración de la onda S.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-AVL
100479-5IC OP Prog note
100480-3IR OP Prog note
100481-1OP MCS+progress note
100482-9MAiD OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. medische zorg bij sterven (document)
100483-7Mental health OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. geestelijke gezondheidszorg (document)
100484-5Multi-spec prog OP Prog note
100485-2Neo peri med OP Prog note
100486-0Nephrology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. nefrologie (document)
10048-7S wave dur L-AVRduración de la onda S.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-AVR
100487-8Neuro surgery OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. neurochirurgie (document)
100488-6Neurology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. neurologie (document)
100489-4Child neuro OP Prog note
100490-2Nurse pract OP Prog note
100491-0Nurse OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. verpleegkundige (document)
100492-8Nutr+diet OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. voeding en diëtetiek (document)
100493-6OBGYN OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie en gynaecologie (document)
100494-4OB OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie (document)
10049-5S wave dur L-Iduración de la onda S.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Conduzca I:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-I
100495-1OT OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. bezigheidstherapie (document)
100496-9Oncology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. oncologie (document)
100497-7Ophthalmol OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. oogheelkunde (document)
100498-5Optometry OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. optometrie (document)
100499-3OMS OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. oromaxillofaciale chirurgie (document)
100500-8Orthopaedic surgery OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. orthopedische chirurgie (document)
100501-6Orthotics prosthetics OP Prog note
100502-4Otolaryngology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. KNO (document)
10050-3S wave dur L-IIduración de la onda S.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-II
100503-2Pain medicine OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. pijnbestrijding (document)
100504-0Palliative care OP Prog note
100505-7Peds cardiology OP Prog note
100506-5Peds dermatology OP Prog note
100507-3Peds endocrinology OP Prog note
100508-1Peds gastroenterology OP Prog note
100509-9Peds hem-onc OP Prog note
100510-7Peds infect disease OP Prog note
10051-1S wave dur L-IIIduración de la onda S.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-III
100511-5Peds otolaryngology OP Prog note
100512-3Peds pulmonology OP Prog note
100513-1Peds rheumatology OP Prog note
100514-9Peds surgery OP Prog note
100515-6Peds transpl hepato OP Prog note
100516-4Peds urology OP Prog note
100517-2Pharmacogenomics OP Prog note
100518-0PM+R OP Prog note
100519-8PT OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. fysiotherapie (document)
100520-6Plastic surgery OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. plastische chirurgie (document)
100521-4Podiatry OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. podologie (document)
100522-2Psychiatric Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. psychiatrie (document)
100523-0Psych OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. psychologie (document)
100524-8Pulmonary disease OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. longaandoening (document)
100525-5Radiation Onc OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. radiotherapie (document)
100526-3Radiology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. radiologie (document)
100527-1Rec therapy OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. recreationele therapie (document)
100528-9REI OP Prog note
10052-9S wave dur L-V1duración de la onda S.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-V1
100529-7Research OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. wetenschappelijk onderzoek (document)
100530-5Rheumatology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. reumatologie (document)
100531-3Sleep med OP Prog note
100532-1SW OP Prog note
100533-9Solid Org Transplant OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. transplantatie van solide orgaan (document)
100534-7Speech-lang path OP Prog note
100535-4Spinal surgery OP Prog note
100536-2Sports medicine OP Prog note
10053-7S wave dur L-V2duración de la onda S.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-V2
100537-0Hand Surgery OP Prog note
100538-8Telehealth+Outpatient Prog note
100539-6Thromboemb OP Prog note
100540-4Transpl surg OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. transplantatiechirurgie (document)
100541-2Trauma OP Prog note
100542-0Urology OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. urologie (document)
100543-8Vasc Neuro OP Prog note
100544-6Vascular surgery OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. vaatchirurgie (document)
10054-5S wave dur L-V3duración de la onda S.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-V3
100545-3Wound care management OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. wondzorg (document)
100546-1WOC OP Prog note
100547-9Adolescent med Hosp Prog note
100548-7Allergy+Immunology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. allergie+immunologie (document)
100549-5Allergy Hosp Prog note
100550-3Attend Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. behandelend arts (document)
100551-1Audiology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. audiologie (document)
10055-2S wave dur L-V4duración de la onda S.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-V4
100552-9Bariatric surg Hosp Prog note
100553-7Bld Bnk+Trans Med Hosp Prog note
100554-5BM Transplant Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. beenmergtransplantatie (document)
100555-2Breastfeeding Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. borstvoeding (document)
100556-0Burn Hosp Prog note
100557-8Cardiac surgery Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. cardiochirurgie (document)
100558-6Cardio+Pulm disease Hosp Prog note
100559-4Child+teen psych Hosp Prog note
10056-0S wave dur L-V5duración de la onda S.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-V5
100560-2Electrophysiology Hosp Prog note
100561-0Clinical genetics Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. klinische genetica (document)
100562-8Clinical Neurophys Hosp Prog note
100563-6Clin Path Hosp Prog note
100564-4Col+rec surg Hosp Prog note
100565-1Consultant Hosp Prog note
100566-9Dentistry Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. tandheelkunde (document)
100567-7Dermatology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. dermatologie (document)
100568-5Develop-behav peds Hosp Prog note
100569-3Dialy+Ther Apher Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. dialyse en therapeutische aferese (document)
100570-1Eating disorders Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. eetstoornis (document)
100571-9Endocrinology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. endocrinologie (document)
100572-7Fam Med Hosp Prog note
100573-5Gastroenterology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. gastro-enterologie (document)
100574-3General medicine Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. algemene geneeskunde (document)
100575-0Geri med Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. geriatrie (document)
100576-8Gyn Onc Hosp Prog note
100577-6Gynecology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. gynaecologie (document)
10057-8S wave dur L-V6duración de la onda S.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS onda dur L-V6
100578-4Navigator Hosp Prog note
100579-2Heart failure Hosp Prog note
1005-8Indirect Antiglobulin Test (IAT; Indirect Coombs), Bloodprueba de antiglobulina indirecta.reactivo específico de IgG [Inmunoglobulina G]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal:Prueba de antiglobulina indirecta Reactivo específico IgG: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal:Test indirect à l'antiglobuline (TIA) IgG spécifique [Présence/Seuil] Sérum/Plasma ; QualitatifIndirecte antiglobulinetest.IgG-specifiek reagent [aanwezigheid] in serum of plasmaIAT IgG-Sp Reag SerPl Ql
100580-0HF+TC Hosp Prog note
100581-8Hematology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie (document)
100582-6HemOnc Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie + oncologie (document)
100583-4Hepatology Hosp Prog note
100584-2Immunology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. immunologie (document)
100585-9Infectious disease Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. infectioloog (document)
10058-6S' wave Amp L-AVFamplitud de la onda S'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-AVF
100586-7Internal Med Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. interne geneeskunde (document)
100587-5IC Hosp Prog note
100588-3IR Hosp Prog note
100589-1Hosp MCS+progress note
100590-9MAiD Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. medische zorg bij sterven (document)
100591-7Mental health Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. geestelijke gezondheidszorg (document)
100592-5Multi-spec prog Hosp Prog note
100593-3Neo peri med Hosp Prog note
10059-4S' wave Amp L-AVLamplitud de la onda S'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. Conduzca AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-AVL
100594-1Nephrology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. nefrologie (document)
100595-8Neuro surgery Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. neurochirurgie (document)
100596-6Neurology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. neurologie (document)
100597-4Child neuro Hosp Prog note
100598-2Nurse pract Hosp Prog note
100599-0Nurse Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. verpleegkundige (document)
100600-6Nutr+diet Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. voeding en diëtetiek (document)
100601-4OBGYN Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie en gynaecologie (document)
10060-2S' wave Amp L-AVRamplitud de la onda S'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. Conduzca AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-AVR
100602-2OB Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie (document)
100603-0OT Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. bezigheidstherapie (document)
100604-8Oncology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. oncologie (document)
100605-5Ophthalmol Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. oogheelkunde (document)
100606-3OMS Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. oromaxillofaciale chirurgie (document)
100607-1Orthopaedic surgery Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. orthopedische chirurgie (document)
100608-9Orthotics prosthetics Hosp Prog note
100609-7Otolaryngology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. KNO (document)
10061-0S' wave Amp L-Iamplitud de la onda S'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-I
100610-5Pain medicine Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. pijnbestrijding (document)
100611-3Palliative care Hosp Prog note
100612-1Pastoral Care Hosp Prog note
100613-9Peds cardiology Hosp Prog note
100614-7Peds dermatology Hosp Prog note
100615-4Peds endocrinology Hosp Prog note
100616-2Peds gastroenterology Hosp Prog note
100617-0Peds hem-onc Hosp Prog note
100618-8Peds infect disease Hosp Prog note
100619-6Peds otolaryngology Hosp Prog note
100620-4Peds pulmonology Hosp Prog note
100621-2Peds rheumatology Hosp Prog note
100622-0Peds surgery Hosp Prog note
100623-8Peds transpl hepato Hosp Prog note
100624-6Pharmacogenomics Hosp Prog note
100625-3Pharmacology Hosp Prog note
100626-1PM+R Hosp Prog note
100627-9PT Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. fysiotherapie (document)
10062-8S' wave Amp L-IIamplitud de la onda S'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-II
100628-7Plastic surgery Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. plastische chirurgie (document)
100629-5Podiatry Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. podologie (document)
100630-3Psych Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. psychologie (document)
100631-1Radiation Onc Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. radiotherapie (document)
100632-9Radiology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. radiologie (document)
100633-7Rapid response team Hosp Prog note
100634-5Rec therapy Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. recreationele therapie (document)
100635-2REI Hosp Prog note
10063-6S' wave Amp L-IIIamplitud de la onda S'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-III
100636-0Research Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. wetenschappelijk onderzoek (document)
100637-8Rheumatology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. reumatologie (document)
100638-6Sleep med Hosp Prog note
100639-4SW Hosp Prog note
100640-2Solid Org Transplant Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. transplantatie van solide orgaan (document)
100641-0Speech-lang path Hosp Prog note
100642-8Spinal surgery Hosp Prog note
100643-6Hand Surgery Hosp Prog note
10064-4S' wave Amp L-V1amplitud de la onda S'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-V1
100644-4Thromboemb Hosp Prog note
100645-1Trauma Hosp Prog note
100646-9Urology Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. urologie (document)
100647-7Vasc Neuro Hosp Prog note
100648-5Vascular surgery Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. vaatchirurgie (document)
100649-3Wound care management Hosp Prog noteVoortgangsrapport [bevinding] in ziekenhuis d.m.v. wondzorg (document)
100650-1WOC Hosp Prog note
10065-1S' wave Amp L-V2amplitud de la onda S'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-V2
100651-9Hosp COVID-19 Intub+Progress
100652-7Pure tone bone thresh Pnl
100653-5Pure tone air thresh Pnl
100654-3M2-PK (Pyruvatkinase) /StuhlPyruvate kinase M2, StoolPyruvate kinase M2 [Présence/Seuil] Selle ; QualitatifPyruvaatkinase M2 [aanwezigheid] in feces
100655-0XR ST Lat
100656-8Mat fetal med OP Prog note
100657-6Mat fetal med Phone+Hosp Prog note
100658-4Hosp COVID-19 Progress note
100659-2Mat fetal med Hosp Prog note
1006-6Direkt-Antiglobulintest.IgG-spezifisches Reagenz [Interpretation] auf ErythrozytenDirect Antiglobulin Test (DAT; Direct Coombs), Red blood cellsprueba de antiglobulina directa.reactivo específico de IgG [Inmunoglobulina G]:impresión/interpretación del estudio:punto en el tiempo:eritrocitos:Nominal:Prueba de antiglobulina directa Reactivo específico IgG: Eritrocitos : Punto temporal: Impresión / interpretación del estudio: Nominal:Test direct à l'antiglobuline (EDA) IgG spécifique [Interprétation] Érythrocytes ; Résultat nominalDirecte antiglobulinetest.IgG specifiek reagens [interpretatie] in erytrocytenDAT IgG-Sp Reag RBC-Imp
100660-0Mat fetal med Phone+OP Prog note
100661-8Psychiatric OP Prog noteVoortgangsrapport [bevinding] in poliklinisch d.m.v. psychiatrie (document)
100662-6Cortisol free and total panel, BloodCortisol libre et total panel [-] Sérum/Plasma ; -Cortisol vrij & totaal panel in serum of plasma
100663-4TPMT gene c.460G>A&c.719A>G, BloodTPMT gène c.460G>A et c.719A>G [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaireTPMT-gen c.460G>A&c.719A>G [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek
100664-2NUDT15 gene c.50_55dup&c.415C>T, BloodNUDT15 gène c.50_55dup et c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaireNUDT15-gen c.50_55dup&c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek
100665-9NUDT15 gene c.415C>T, BloodNUDT15 gène c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaireNUDT15-gen c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek
100666-7NUDT15 gene c.52G>A, BloodNUDT15 gène c.416G>A [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaireNUDT15-gen c.416G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek
100667-5NUDT15 gene c.52G>A, BloodNUDT15 gène c.52G>A [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaireNUDT15-gen c.52G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek
100668-3NUDT15 gene c.50_55dup, BloodNUDT15 gène c.50_55dup [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaireNUDT15-gen c.50_55dup [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek
10066-9S' wave Amp L-V3amplitud de la onda S'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-V3
100669-1NUDT15 gene c.50_55del, BloodNUDT15 gène c.50_55del [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaireNUDT15-gen c.50_55del [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek
100670-9Fetal RHD gene allele--fetusRHD gène allèle du fœtus [Identification] Plasma avec ADN libre circulant ; Résultat nominalRHD-allel^foetus [identificator] in plasma.celvrij DNA
100671-7Aspergillus sp, BloodAspergillus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cibleAspergillus sp. DNA [aanwezigheid] in bloed d.m.v. probe-detectie
100672-5Aspergillus fumigatus, BloodAspergillus fumigatus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cibleAspergillus fumigatus DNA [aanwezigheid] in bloed d.m.v. probe-detectie
100673-3Aspergillus terreus, BloodAspergillus terreus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cibleAspergillus terreus DNA [aanwezigheid] in bloed d.m.v. probe-detectie
100674-1BK virus, BloodBK virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cibleBK-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie
100675-8Cytomegalie-Virus DNA [Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit SondendetektionCytomegalovirus (CMV), BloodCytomégalovirus ADN [Arbitraire/Volume] Sang ; Numérique ; PCR amplification de cibleCytomegalovirus DNA [eenheid/volume] in bloed d.m.v. probe-detectie
100676-6Cytomegalie-Virus DNA [log Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit SondendetektionCytomegalovirus (CMV), BloodCytomégalovirus ADN [Log arbitraire/Volume] Sang ; Numérique ; PCR amplification de cibleCytomegalovirus DNA [logaritmische eenheid/volume] in bloed d.m.v. probe-detectie
10067-7S' wave Amp L-V4amplitud de la onda S'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-V4
100677-4Epstein Barr virus (EBV), BloodEpstein barr virus ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cibleEpstein-Barr-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie
100678-2Epstein Barr virus (EBV), BloodEpstein barr virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cibleEpstein-Barr-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie
100679-0Herpes virus (HHV) 6, BloodHerpes virus 6 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cibleHumaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie
100680-8Herpes virus (HHV) 6, BloodHerpes virus 6 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cibleHumaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie
100681-6Herpes virus (HHV) 7, BloodHerpes virus 7 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cibleHumaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie
100682-4Herpes virus (HHV) 7, BloodHerpes virus 7 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cibleHumaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie
100683-2Herpes virus (HHV) 8, BloodHerpes virus 8 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cibleHumaan herpesvirus 8 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie
100684-0Herpes virus (HHV) 8, BloodHerpes virus 8 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cibleHumaan herpesvirus 8 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie
10068-5S' wave Amp L-V5amplitud de la onda S'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-V5
100685-7JC virus, BloodJC virus ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cibleJC-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie
100686-5JC virus, Spinal fluidJC virus ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cibleJC-virus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie
100687-3JC virus, UrineJC virus ADN [Log Nombre/Volume] Urine ; Numérique ; PCR amplification de cibleJC-virus DNA [logaritmisch aantal/volume] in urine d.m.v. probe-detectie
100688-1Parvovirus B19 DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit SondendetektionParvovirus B19, BloodParvovirus B19 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cibleParvovirus B19 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie
100689-9Toxoplasma gondii DNA [log #/Volumen] in Serum oder Plasma mittels Nukleinsäureamplifikation mit SondendetektionToxoplasma gondii, BloodToxoplasma gondii ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cibleToxoplasma gondii DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie
100690-7Toxoplasma gondii DNA [log #/Volumen] in Liquor mittels Nukleinsäureamplifikation mit SondendetektionToxoplasma gondii, Spinal fluidToxoplasma gondii ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cibleToxoplasma gondii DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie
100691-5Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit SondendetektionVaricella zoster virus (VZV; Chickenpox), BloodVaricelle zona virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cibleVaricella-zostervirus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie
100692-3Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Liquor mittels Nukleinsäureamplifikation mit SondendetektionVaricella zoster virus (VZV; Chickenpox), Spinal fluidVaricelle zona virus ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cibleVaricella-zostervirus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie
10069-3S' wave Amp L-V6amplitud de la onda S'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaAmplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKGS' onda Amp L-V6
100693-1Pneumocystis jiroveci, Respiratory system specimenPneumocystis jiroveci ADN [Log Nombre/Volume] Respiratoire ; Numérique ; PCR amplification de ciblePneumocystis jiroveci DNA [logaritmisch aantal/volume] in respiratoir monster d.m.v. probe-detectie
100694-9SMN1 gene silent carrier analysis, Blood or tissue specimenSMN1 gène analyse des porteurs silencieux [Présence/Seuil] Sang/Tissu ; Qualitatif ; Biologie moléculaireStille drager van SMN1-gen analyse [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100695-6Genetic disease analysis overall carrier interpretation, Blood or tissue specimenMaladie génétique transmise interprétation globale [Interprétation] Sang/Tissu ; Résultat textuel ; Biologie moléculaire
100696-4CTNS related multigene analysis, Body Fld+S/PAnalyse multigénique en relation avec le CTNS [Identification] Liquide biologique+Sérum/Plasma ; Résultat nominal ; Biologie moléculaireCTNS-gerelateerde multigen-analyse [identificator] in lichaamsvloeistof en serum of plasma d.m.v. moleculair genetisch onderzoek
100697-2IR OP Note
100698-0SDOH screen report Doc
100699-8Susceptibility to Rifabutin+EthambutolRifabutine+éthambutol [Sensibilité] Isolat ; AlphanumériqueRifabutine + ethambutol [gevoeligheid] in isolaat
100700-4Trichomonas vaginalis, UrethraTrichomonas vaginalis ADN [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cibleTrichomonas vaginalis DNA [aanwezigheid] in urethra d.m.v. probe-detectie
10070-1S' wave dur L-AVFduración de la onda S'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-AVF
100701-2Trichomonas vaginalis, UrethraTrichomonas vaginalis ARNr [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cibleTrichomonas vaginalis rRNA [aanwezigheid] in urethra d.m.v. probe-detectie
100702-0Mycoplasma genitalium rRNA [Nachweis] in Harnröhre mittels Nukleinsäureamplifikation mit SondendetektionMycoplasma genitalium, UrethraMycoplasma genitalium ARNr [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cibleMycoplasma genitalium rRNA [aanwezigheid] in urethra d.m.v. probe-detectie
100703-8Mycoplasma genitalium rRNA [Nachweis] in Urin mittels Nukleinsäureamplifikation mit SondendetektionMycoplasma genitalium, UrineMycoplasma genitalium ARNr [Présence/Seuil] Urine ; Qualitatif ; PCR amplification de cibleMycoplasma genitalium rRNA [aanwezigheid] in urine d.m.v. probe-detectie
100704-6Mycoplasma genitalium rRNA [Nachweis] in Zervix mittels Nukleinsäureamplifikation mit SondendetektionMycoplasma genitalium, CervixMycoplasma genitalium ARNr [Présence/Seuil] Col de l'utérus ; Qualitatif ; PCR amplification de cibleMycoplasma genitalium rRNA [aanwezigheid] in cervix d.m.v. probe-detectie
100705-3Mycoplasma genitalium rRNA [Nachweis] in anorektalem Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionMycoplasma genitalium, AnorectalMycoplasma genitalium ARNr [Présence/Seuil] Anorectal ; Qualitatif ; PCR amplification de cibleMycoplasma genitalium rRNA [aanwezigheid] in anorectaal d.m.v. probe-detectie
100706-1Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionMycoplasma genitalium, SpecimenMycoplasma genitalium ARNr [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cibleMycoplasma genitalium rRNA [aanwezigheid] d.m.v. probe-detectie
100707-9Polymorphonuclear cells, Peritoneal dialysis fluidCellules polymorphonucléaires [Nombre/Volume] Liquide de dialyse péritonéale ; Numérique ; Comptage automatePolymorfonucleaire cellen [aantal/volume] in periteonale dialysevloeistof d.m.v. geautomatiseerde telling
100708-7Plasma cells per 100 white blood cells, Synovial fluidPlasmocytes/100 leucocytes [Fraction de nombres] Liquide synovial ; NumériquePlasmacellen/100 leukocyten [getalsfractie] in synoviaal vocht
100709-5Hepatocellular carcinoma riskRisque de cancer hépatocellulaire [Score] Patient ; Numérique ; GAADRisico op hepatocellulair carcinoom [score] d.m.v. GAAD-score
100710-3Chlamydia trachomatis and Neisseria gonorrhoeae panel, ThroatChlamydia trachomatis et Neisseria gonorrhoeae ARNr panel [-] Gorge ; - ; PCR amplification de cibleChlamydia trachomatis & Neisseria gonorrhoeae rRNA panel in keel d.m.v. probe-detectie
100711-1Borrelia burgdorferi.VlsE1+pepC10 Antikörper [Einheiten/Volumen] in Serum mittels ImmunoassayBorrelia burgdorferi.VlsE1+pepC10 antibody, BloodBorrelia burgdorferi VlsE1+pepC10 Ac [Arbitraire/Volume] Sérum ; Numérique ; ImmunoanalyseBorrelia burgdorferi.VlsE1+pepC10 As [eenheid/volume] in serum d.m.v. immunoassay
100712-9Brexpiprazole, BloodBrexpiprazole [Masse/Volume] Sérum/Plasma ; NumériqueBrexpiprazol [massa/volume] in serum of plasma
100713-7Cariprazine, BloodCariprazine [Masse/Volume] Sérum/Plasma ; NumériqueCariprazine [massa/volume] in serum of plasma
100714-5Guanfacine, BloodGuanfacine [Masse/Volume] Sérum/Plasma ; NumériqueGuanfacine [massa/volume] in serum of plasma
100715-2Prothipendyl, BloodProthipendyl [Masse/Volume] Sérum/Plasma ; NumériqueProthipendyl [massa/volume] in serum of plasma
100716-0Prostate specific antigen, Dried blood spotProstate spécifique antigène [Masse/Volume] Sang buvard ; NumériqueProstaatspecifiek Ag [massa/volume] in gedroogde bloedspot
100717-8FCGR3A gene.p.Phe176Val, Blood or tissue specimenFCGR3A gène p.Phe176Val [Présence/Seuil] Sang/Tissu ; Qualitatif ; Biologie moléculaireFCGR3A-gen.p.Phe176Val [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek
100718-6Undersea+hyperbar D/C sum
10071-9S' wave dur L-AVLduración de la onda S'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Liderar AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-AVL
100719-4Surg Onc D/C sum
100720-2REI D/C sum
100721-0Comm hlth care D/C sum
100722-8Integrative medicine D/C sum
100723-6Sports medicine D/C sum
100724-4Diabetology D/C sumSamenvattende ontslagbrief [bevinding] in {instelling} d.m.v. diabetologie (document)
100725-1Optometry D/C sumSamenvattende ontslagbrief [bevinding] in {instelling} d.m.v. optometrie (document)
100726-9Podiatry D/C sumSamenvattende ontslagbrief [bevinding] in {instelling} d.m.v. podologie (document)
10072-7S' wave dur L-AVRduración de la onda S'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. adelantar AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-AVR
100727-7Chiropractic med D/C sumSamenvattende ontslagbrief [bevinding] in {instelling} d.m.v. chiropractie (document)
100728-5Cardiac surgery D/C sumSamenvattende ontslagbrief [bevinding] in {instelling} d.m.v. cardiochirurgie (document)
100729-3Breastfeeding D/C sumSamenvattende ontslagbrief [bevinding] in {instelling} d.m.v. borstvoeding (document)
100730-1Transpl surg D/C sumSamenvattende ontslagbrief [bevinding] in {instelling} d.m.v. transplantatiechirurgie (document)
100731-9Urgent care D/C sum
100732-7Cholesterol.in lipoprotein (little a) & Cholesterol.in LDL panel, BloodCholesterol Lp(a) et cholesterol LDL panel [-] Sérum ; -Cholesterol.in lipoproteïne (kleine a) & cholesterol.in LDL panel in serum
100733-5LDL cholesterol corrected for Cholesterol.in lipoprotein (little a), BloodCholestérol LDL corrigé par cholestérol Lp(a) [Masse/Volume] Sérum ; Numérique ; Résultat calculéCholesterol.in LDL^gecorrigeerd voor cholesterol.in lipoproteïne (kleine a) [massa/volume] in serum d.m.v. berekend
100734-3traMADol and Metabolites Panel, UrineTramadol et métabolites panel [-] Urine ; - ; ConfirmationTramadol & metabolieten panel in urine d.m.v. bevestiging
10073-5S' wave dur L-Iduración de la onda S'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-I
100735-0Mannose-6-phosphate isomerase and phosphomannomutase 1 panel, White blood cellsMannose-6-phosphate isomérase et phosphomannomutase 1 panel [-] Leucocytes ; -Mannose-6-fosfaatisomerase & fosfomannomutase 1 panel in leukocyten
100736-8Acylcarnitine Analysis Post Mortem, SpecimenAcylcarnitine post-mortem [Recherche] Milieux divers ; DocumentAcylcarnitine postmortale analyse [bevinding] (document)
100737-6Alkaline phosphatase.macromolecular, BloodPhosphatase alcaline macroenzyme [Présence/Seuil] Sérum/Plasma ; QualitatifAlkalinefosfatase.macromoleculair [aanwezigheid] in serum of plasma
100738-4Macromolecular alanine aminotransferase, BloodAlanine aminotransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; QualitatifAlanine-aminotransferase.macromoleculair [aanwezigheid] in serum of plasma
100739-2Macromolecular aspartate aminotransferase, BloodAspartate aminotransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; QualitatifAspartaataminotransferase.macromoleculair [aanwezigheid] in serum of plasma
1007-4DCT polyspez.Direkt-Antiglobulintest.polyspezifisches Reagenz [Nachweis] auf ErythrozytenDirect Antiglobulin Test (DAT; Direct Coombs), Red blood cellsprueba de antiglobulina directa.reactivo poliespecífico:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal:Prueba de antiglobulina directa, reactivo específico de poli: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal:Test direct à l'antiglobuline (EDA) polyvalente [Présence/Seuil] Érythrocytes ; QualitatifDirecte antiglobulinetest.polyspecifiek reagens [aanwezigheid] in erytrocytenDAT Poly-Sp Reag RBC Ql
100740-0Amylase.macromolecular, BloodAmylase macroenzyme [Présence/Seuil] Sérum/Plasma ; QualitatifAmylase.macromoleculair [aanwezigheid] in serum of plasma
100741-8Gamma glutamyl transferase.macromolecular, BloodGamma glutamyltransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; QualitatifGamma-glutamyltransferase.macromoleculair [aanwezigheid] in serum of plasma
100742-6Lactate dehydrogenase.macromolecular, BloodLactate déhydrogénase macroenzyme [Présence/Seuil] Sérum/Plasma ; QualitatifLactaatdehydrogenase.macromoleculair [aanwezigheid] in serum of plasma
10074-3S' wave dur L-IIduración de la onda S'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-II
100743-4Lipase.macromolecular, BloodLipase macroenzyme [Présence/Seuil] Sérum/Plasma ; QualitatifLipase.macromoleculair [aanwezigheid] in serum of plasma
100744-2Alpha-1-acid glycoprotein, BloodOrosomucoïde [Masse/Volume] Sérum/Plasma ; Numérique ; ÉlectrophorèseAlfa-1-zure glycoproteïne [massa/volume] in serum of plasma d.m.v. elektroforese
100745-9Chloride, BloodChlore [Moles/Volume] Sang mêlé veineux ; NumériqueChloride [mol/volume] in gemengd veneus bloed
100746-7Glucose, BloodGlucose [Moles/Volume] Sang mêlé veineux ; NumériqueGlucose [mol/volume] in gemengd veneus bloed
100747-5Legionella serogroup panel, SpecimenLegionella sérogroupe panel [-] Milieux divers ; -Legionella serogroep panel
100748-3Legionella spp [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionLegionella spp, SpecimenLegionella spp [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cibleLegionella spp. [aanwezigheid] d.m.v. probe-detectie
100749-1Legionella pneumophila, Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionLegionella pneumophila serogroup 1, SpecimenLegionella pneumophila sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cibleLegionella pneumophila serogroep 1 [aanwezigheid] d.m.v. probe-detectie
10075-0S' wave dur L-IIIduración de la onda S'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-III
100750-9Legionella pneumophila, nicht Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionLegionella pneumophila non-serogroup 1, SpecimenLegionella pneumophila non sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cibleLegionella pneumophila anders dan serogroep 1 [aanwezigheid] d.m.v. probe-detectie
100751-7Galactose-alpha-1,3-galactose (Alpha-Gal) panel, BloodGalactose-alpha-1,3-galactose panel [-] Sérum/Plasma ; -Galactose-alfa-1,3-galactose panel in serum of plasma
100752-5Exacerbating factors Reported
100753-3Alleviating factors Reported
100754-1Platelet disorders multigene analysis, Blood or tissue specimenAnalyse multigénique des troubles plaquettaires [Recherche] Sang/Tissu ; Document ; SéquençageTrombocytopathie multigen-analyse [bevinding] in bloed of weefsel d.m.v. sequencing (document)
100755-8Oligoclonal bands, BloodProtéines fractions oligoclonales [Nombre] Sérum/Plasma ; Numérique ; IsoélectrofocalisationEiwitfracties.oligoklonale banden [aantal] in serum of plasma d.m.v. iso-elektrisch focusseren
100756-6Oligoclonal bands, Spinal fluidProtéines fractions oligoclonales [Interprétation] Liquide céphalorachidien ; Résultat nominal ; IsoélectrofocalisationEiwitfracties.oligoklonale banden [interpretatie] in liquor cerebrospinalis d.m.v. iso-elektrisch focusseren
100757-4Protein fractions.oligoclonal bands panel, Serum+Cerebrospinal fluidProtéines fractions oligoclonales panel [-] Sérum+Liquide céphalorachidien ; - ; IsoélectrofocalisationEiwitfracties.oligoklonale banden panel in serum en liquor cerebrospinalis d.m.v. iso-elektrisch focusseren
100758-2Estimated lung age from clin data
100759-0Inspiratory reserve vol spirometry
100760-8XR Radius+Ulna-L 1V
100761-6PALB2 gene targeted mutation analysis, Blood or tissue specimenPALB2 gène mutation cible trouvée [Recherche] Sang/Tissu ; Document ; Biologie moléculairePALB2-gen doelgerichte mutatie-analyse [bevinding] in bloed of weefsel d.m.v. moleculair genetisch onderzoek (document)
100762-4HBA2 gene.c.377T>C, BloodHBA2 gène c.377T>C [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaireHBA2-gen.c.377T>C [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek
100763-2Mycobacterium sp comparative reaction interpretation, SkinComparatieve reactie op Mycobacterium sp. Interpretatie [interpretatie] in huid (tekstueel)
100764-0Mycobacterium bovis reaction wheal 3 days after Mammalian Tuberculin Intradermal, SkinMycobacterium bovis huidreactie^3 dagen na dosis zoogdiertuberculine ID [diameter] in huid
100765-7Homocysteine and Methylmalonate and Methylcitrate panel, Dried blood spotHomocystéine et méthylmalonate et 2-méthylcitrate panel [-] Sang buvard ; -Homocysteïne & methylmalonaat & 2-methylcitraat panel in gedroogde bloedspot
100766-5Center for Epidemiologic Studies Depression Scale panel [CES-D]
100767-3Bothered by things that are not usually bothersome
10076-8S' wave dur L-V1duración de la onda S'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-V1
100768-1Poor appetite
100769-9Unhappy even with help from my family or friends
100770-7Feeling just as good as others
100771-5Trouble focusing
100772-3Feeling depressed
100773-1Feeling everything is too much of an effort
100774-9Feeling hopeful about the future
100775-6Feeling life had been a failure
10077-6S' wave dur L-V2duración de la onda S'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-V2
100776-4Feeling fearful
100777-2Restless sleep
100778-0Feeling happy
100779-8Quieter than usual
100780-6Feeling lonely
100781-4People were unfriendly
100782-2Enjoying life
100783-0Crying spells
10078-4S' wave dur L-V3duración de la onda S'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-V3
100784-8Feeling sad
100785-5Feeling people dislike me
100786-3Lack of energy
100787-1Total Score CES-D
100788-9Stemphylium botryosum IgG4 antibodyStemphylium botryosum Ac IgG4 [Masse/Volume] Sérum ; NumériqueStemphylium botryosum As.IgG4 [massa/volume] in serum
100789-7Rhizopus nigricans IgG4 antibodyRhizopus nigricans Ac IgG4 [Masse/Volume] Sérum ; NumériqueRhizopus nigricans As.IgG4 [massa/volume] in serum
100790-5Lepidoglyphus destructor IgG antibodyLepidoglyphus destructor Ac IgG [Masse/Volume] Sérum ; NumériqueLepidoglyphus destructor As.IgG [massa/volume] in serum
100791-3Hamster epithelium IgG antibodyHamster (épithélium) Ac IgG [Masse/Volume] Sérum ; NumériqueHamsterepitheel As.IgG [massa/volume] in serum
10079-2S' wave dur L-V4duración de la onda S'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-V4
100792-1Forsythia allergy testForsythia Ac IgE [Arbitraire/Volume] Sérum ; NumériqueForsythia As.IgE [eenheid/volume] in serum
100793-9Testosterone, Body fluidTestostérone [Masse/Volume] Liquide biologique ; NumériqueTestosteron [massa/volume] in lichaamsvocht
100794-7Follitropin (FSH; Follicle Stimulating Hormone), Body fluidFolliculostimuline [Arbitraire/Volume] Liquide biologique ; NumériqueFollikelstimulerend hormoon [eenheid/volume] in lichaamsvocht
100795-4S100 Calcium Binding Protein B, Body fluidProtéine S100B [Masse/Volume] Liquide biologique ; NumériqueS100 calciumbindend eiwit B [massa/volume] in lichaamsvocht
100796-2Thyroglobulin, Body fluidThyroglobuline [Masse/Volume] Liquide biologique ; NumériqueThyreoglobuline [massa/volume] in lichaamsvocht
100797-0Free testosterone 1st specimen after challenge, BloodTestostérone libre T01 après épreuve [Masse/Volume] Sérum ; NumériqueTestosteron.vrij^1ste monster na XXX belasting [massa/volume] in serum
100798-8Free testosterone 2nd specimen after challenge, BloodTestostérone libre T02 après épreuve [Masse/Volume] Sérum ; NumériqueTestosteron.vrij^2de monster na XXX belasting [massa/volume] in serum
100799-621-Deoxycortisol 1st specimen after challenge, Blood21-déoxycortisol T01 après épreuve [Masse/Volume] Sérum ; Numérique21-deoxycortisol^1ste monster na XXX belasting [massa/volume] in serum
100-8Cefoperazon [Empfindlichkeit] mittels Bestimmung der minimalen Hemmkonzentration (MHK)Susceptibility to Cefoperazonecefoperazona:susceptibilidad:punto en el tiempo:cepa clínica:ordinal o cuantitativo:concentración inhibitoria mínimaCefoperazona: Aislado : Punto temporal: Susceptibilidad (microorganismos): Ordinal Cuantitativo: Concentración mínima inhibitoria (MIC)Céfopérazone [Sensibilité] Isolat ; Alphanumérique ; CMICefoperazon [gevoeligheid] in isolaat d.m.v. minimaal inhiberende concentratieCefoperazone Islt MIC
10080-0S' wave dur L-V5duración de la onda S'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-V5
100800-221-Deoxycortisol 2nd specimen after challenge, Blood21-déoxycortisol T02 après épreuve [Masse/Volume] Sérum ; Numérique21-deoxycortisol^2de monster na XXX belasting [massa/volume] in serum
100801-021-Deoxycortisol 3rd specimen after challenge, Blood21-déoxycortisol T03 après épreuve [Masse/Volume] Sérum ; Numérique21-deoxycortisol^3de monster na XXX belasting [massa/volume] in serum
100802-821-Deoxycortisol 4th specimen after challenge, Blood21-déoxycortisol T04 après épreuve [Masse/Volume] Sérum ; Numérique21-deoxycortisol^4de monster na XXX belasting [massa/volume] in serum
100803-621-Deoxycortisol 5th specimen after challenge, Blood21-déoxycortisol T05 après épreuve [Masse/Volume] Sérum ; Numérique21-deoxycortisol^5de monster na XXX belasting [massa/volume] in serum
100804-4Vasopressin 1st specimen after challenge, BloodVasopressine T01 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^1ste monster na XXX belasting [mol/volume] in plasma
100805-1Vasopressin 2nd specimen after challenge, BloodVasopressine T02 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^2de monster na XXX belasting [mol/volume] in plasma
100806-9Vasopressin 3rd specimen after challenge, BloodVasopressine T03 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^3de monster na XXX belasting [mol/volume] in plasma
100807-7Vasopressin 4th specimen after challenge, BloodVasopressine T04 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^4de monster na XXX belasting [mol/volume] in plasma
100808-5Vasopressin 5th specimen after challenge, BloodVasopressine T05 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^5de monster na XXX belasting [mol/volume] in plasma
100809-3Vasopressin 6th specimen after challenge, BloodVasopressine T06 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^6de monster na XXX belasting [mol/volume] in plasma
100810-1Vasopressin 7th specimen after challenge, BloodVasopressine T07 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^7de monster na XXX belasting [mol/volume] in plasma
100811-9Vasopressin 8th specimen after challenge, BloodVasopressine T08 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^8ste monster na XXX belasting [mol/volume] in plasma
100812-7Vasopressin 9th specimen after challenge, BloodVasopressine T09 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^9de monster na XXX belasting [mol/volume] in plasma
100813-5Vasopressin 10th specimen after challenge, BloodVasopressine T10 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^10de monster na XXX belasting [mol/volume] in plasma
100814-3Vasopressin 11th specimen after challenge, BloodVasopressine T11 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^11de monster na XXX belasting [mol/volume] in plasma
100815-0Vasopressin 12th specimen after challenge, BloodVasopressine T12 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^12de monster na XXX belasting [mol/volume] in plasma
100816-8Glucagon 6th specimen after challenge, BloodGlucagon T06 après épreuve [Masse/Volume] Sérum/Plasma ; NumériqueGlucagon^6de monster na XXX belasting [massa/volume] in serum of plasma
100817-6Glucagon 7th specimen after challenge, BloodGlucagon T07 après épreuve [Masse/Volume] Sérum/Plasma ; NumériqueGlucagon^7de monster na XXX belasting [massa/volume] in serum of plasma
10081-8S' wave dur L-V6duración de la onda S'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiogramaDuración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKGS' onda dur L-V6
100818-4Renin 1st specimen after challenge, BloodRénine T01 après épreuve [Masse/Volume] Plasma ; NumériqueRenine^1ste monster na XXX belasting [massa/volume] in plasma
100819-2Renin 2nd specimen after challenge, BloodRénine T02 après épreuve [Masse/Volume] Plasma ; NumériqueRenine^2de monster na XXX belasting [massa/volume] in plasma
1008-2ICT polyspez.Indirect Antiglobulin Test (IAT; Indirect Coombs), Bloodprueba de antiglobulina indirecta.reactivo multiespecífico:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal:Prueba de antiglobulina indirecta, reactivo específico de poli: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal:Test indirect à l'antiglobuline (TIA) polyvalente [Présence/Seuil] Sérum/Plasma ; QualitatifIndirecte antiglobulinetest.polyspecifiek reagent [aanwezigheid] in serum of plasmaIAT Poly-Sp Reag SerPl Ql
100820-0Renin 3rd specimen after challenge, BloodRénine T03 après épreuve [Masse/Volume] Plasma ; NumériqueRenine^3de monster na XXX belasting [massa/volume] in plasma
100821-8POLST panel
100822-6Cardiopulmonary resuscitation orders
100823-4Initial portable medical treatment orders
100824-2Additional portable medical orders or instructions
100825-9Medically assisted nutrition orders
10082-6ST I-Amp 6ms L-AVFamplitud inicial del segmento ST, 6 mseg.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaST amplitud inicial 6 ms plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKGST I-Amp 6ms L-AVF
100826-7Portable medical order &or advance directive review
100827-5Portable medical order discussion participants
100828-3Portable medical order administrative information
100829-1Renin 4th specimen after challenge, BloodRénine T04 après épreuve [Masse/Volume] Plasma ; NumériqueRenine^4de monster na XXX belasting [massa/volume] in plasma
100830-9Free alpha subunit 1st specimen after challenge, BloodSous unité alpha libre T01 après épreuve [Arbitraire/Volume] Sérum/Plasma ; NumériqueAlfa-subeenheid.vrij^1ste monster na XXX belasting [eenheid/volume] in serum of plasma
100831-7Free alpha subunit 2nd specimen after challenge, BloodSous unité alpha libre T02 après épreuve [Arbitraire/Volume] Sérum/Plasma ; NumériqueAlfa-subeenheid.vrij^2de monster na XXX belasting [eenheid/volume] in serum of plasma
100832-5Free alpha subunit 3rd specimen after challenge, BloodSous unité alpha libre T03 après épreuve [Arbitraire/Volume] Sérum/Plasma ; NumériqueAlfa-subeenheid.vrij^3de monster na XXX belasting [eenheid/volume] in serum of plasma
100833-3Free alpha subunit 4th specimen after challenge, BloodSous unité alpha libre T04 après épreuve [Arbitraire/Volume] Sérum/Plasma ; NumériqueAlfa-subeenheid.vrij^4de monster na XXX belasting [eenheid/volume] in serum of plasma
10083-4ST I-Amp 6ms L-AVLamplitud inicial del segmento ST, 6 mseg.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaST amplitud inicial 6 ms plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKGST I-Amp 6ms L-AVL
100834-1Free alpha subunit 5th specimen after challenge, BloodSous unité alpha libre T05 après épreuve [Arbitraire/Volume] Sérum/Plasma ; NumériqueAlfa-subeenheid.vrij^5de monster na XXX belasting [eenheid/volume] in serum of plasma
100835-8Free alpha subunit 6th specimen after challenge, BloodSous unité alpha libre T06 après épreuve [Arbitraire/Volume] Sérum/Plasma ; NumériqueAlfa-subeenheid.vrij^6de monster na XXX belasting [eenheid/volume] in serum of plasma
100836-6Free alpha subunit 7th specimen after challenge, BloodSous unité alpha libre T07 après épreuve [Arbitraire/Volume] Sérum/Plasma ; NumériqueAlfa-subeenheid.vrij^7de monster na XXX belasting [eenheid/volume] in serum of plasma
100837-4Insulin-like growth factor-I 9th specimen after challenge, BloodInsulin-like growth factor 1 T09 après épreuve [Masse/Volume] Sérum/Plasma ; NumériqueInsulin-like growth factor-I^9de monster na XXX belasting [massa/volume] in serum of plasma
100838-2Testosterone 9th specimen after challenge, BloodTestostérone T09 après épreuve [Masse/Volume] Sérum/Plasma ; NumériqueTestosteron^9de monster na XXX belasting [massa/volume] in serum of plasma
100839-0Vitamin A/Retinol binding protein, BloodVitamine A/retinol binding protein [Ratio] Sérum/Plasma ; NumériqueRetinol/retinolbindend eiwit [verhouding] in serum of plasma
100840-8IgE, Body fluidImmunoglobuline E [Arbitraire/Volume] Liquide biologique ; NumériqueIgE [eenheid/volume] in lichaamsvocht
100841-6Zinc finger protein of the cerebellum 4 antibody, Spinal fluidZic4 anticorps [Présence/Seuil] Liquide céphalorachidien ; Qualitatif ; Blot en ligneZinc finger proteïne of the cerebellum 4 As [aanwezigheid] in liquor cerebrospinalis d.m.v. lijnblot
10084-2ST I-Amp 6ms L-AVRamplitud inicial del segmento ST, 6 mseg.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaST amplitud inicial 6 ms avance AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKGST I-Amp 6ms L-AVR
100842-4Nonalcoholic steatohepatitis score, BloodStéatohépatite non alcoolique - Score [Score] Sérum/Plasma ; Numérique ; Calculé FAST
100843-2Liver fibrosis score, BloodScore de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile3+
100844-0Liver fibrosis score, BloodScore de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile4
100845-7Neurofascin155 IgG4 antibody, BloodNeurofascine155 Ac IgG4 [Présence/Seuil] Sérum ; Qualitatif ; Cytométrie de fluxNeurofascine155 As.IgG4 [aanwezigheid] in serum d.m.v. flowcytometrie
100846-5Dengue-Virus 1+2+3+4 nsP1 IgG IgG-Antikörper [Nachweis] in Serum oder Plasma mittels ImmunoassayDengue virus 1+2+3+4 nsP1 IgG antibody, BloodDengue virus 1+2+3+4 protéine non structurelle 1 (nsP1) [Présence/Seuil] Sérum/Plasma ; Qualitatif ; ImmunoanalyseDenguevirus 1+2+3+4 niet-structureel proteïne 1 (nsP1) As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay
100847-3Gas and ammonia panel, BloodGaz du sang et ammoniaque panel [-] Sang artériel ; -Gas en ammoniak panel in arterieel bloed
100848-1Cell count and Differential panel, Amniotic fluidNFS - Hémogramme panel [-] Liquide amniotique ; - ; Comptage manuelCeltelling & differentieel panel in vruchtwater d.m.v. manuele telling
100849-9White blood cell (WBC) count, Amniotic fluidLeucocytes [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuelLeukocyten [aantal/volume] in vruchtwater d.m.v. manuele telling
100850-7Neutrophils, Amniotic fluidPolynucléaires neutrophiles [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuelNeutrofielen [aantal/volume] in vruchtwater d.m.v. manuele telling
100851-5Other cells, Amniotic fluidCellules autres [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuelOverige cellen [aantal/volume] in vruchtwater d.m.v. manuele telling
100852-3NM Bones Views for mets W Sr-89 IV
100853-1NM Pericardial effusion
100854-9Lymphocytes per 100 cells, BloodLymphocytes/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique ; ImmunoanalyseLymfocyten/100 cellen [getalsfractie] in mononucleaire cellen in bloed d.m.v. immunoassay
100855-6CD3 cells per 100 cells, BloodCD3/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; NumériqueCellen.CD3/100 cellen [getalsfractie] in mononucleaire cellen in bloed
100856-4CD3+CD4+ (T4 Helper) Cells per 100 cells, BloodCD3+CD4+/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; NumériqueCellen.CD3+CD4+/100 cellen [getalsfractie] in mononucleaire cellen in bloed
100857-2CD3+CD8+ (T8 Suppressor) Cells per 100 cells, BloodCD3+CD8+/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; NumériqueCellen.CD3+CD8+/100 cellen [getalsfractie] in mononucleaire cellen in bloed
100858-0Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-PeptidCells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, BloodCD4+CD154+/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; NumériqueCellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed
10085-9ST I-Amp 6ms L-Iamplitud inicial del segmento ST, 6 mseg.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaST amplitud inicial 6 ms plomo I:Corazón :Punto temporal:Elpot:Cuantitativo:EKGST I-Amp 6ms L-I
100859-8Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-PeptidCells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, BloodCD4 exprimant l'interféron gamma/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; NumériqueCellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed
100860-6Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-PeptidCells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, BloodCD4 exprimant le TNF alpha/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; NumériqueCellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed
100861-4Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-PeptidCells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, BloodCD4+CD154+/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; NumériqueCellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed
100862-2Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-PeptidCells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, BloodCD4 exprimant l'interféron gamma/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; NumériqueCellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed
100863-0Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-PeptidCells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, BloodCD4 exprimant le TNF alpha/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; NumériqueCellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed
100864-8Giardia lamblia bg-Gen [Genotyp] in Probenmaterial mittels MolekulargenetikGiardia lamblia bg gene genotype, SpecimenGiardia lamblia bg gène [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaireGiardia lamblia bg-gen [genotype] d.m.v. moleculair genetisch onderzoek
100865-5Avian schistosomes, SpecimenAviaire Schistosoma DNA [aanwezigheid] d.m.v. probe-detectie
100866-3Febrile antibody profile, BloodProfil d'anticorps fébriles [-] Sérum ; -
10086-7ST I-Amp 6ms L-IIamplitud inicial del segmento ST, 6 mseg.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaST amplitud inicial 6 ms plomo II:Corazón :Punto temporal:Elpot:Cuantitativo:EKGST I-Amp 6ms L-II
100867-1Campylobacter jejuni+coli+lari+upsaliensis Antigen [Nachweis] in Stuhl mittels Immunoassay-SchnelltestCampylobacter jejuni+coli+lari+upsaliensis antigen, StoolCampylobacter jejuni+coli+lari+upsaliensis Ag [Présence/Seuil] Selle ; Qualitatif ; Immunoanalyse rapideCampylobacter jejuni + coli + lari + upsaliensis Ag [aanwezigheid] in feces d.m.v. immunoassay.sneltest
100868-9Cryptosporidium sp 18S-LC2 rRNA [Genotyp] in Probenmaterial mittels MolekulargenetikCryptosporidium sp 18S-LC2 genotype, SpecimenCryptosporidium 18S-LC2 ARNr [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaireCryptosporidium sp. 18S-LC2 rRNA [genotype] d.m.v. moleculair genetisch onderzoek
100869-7Cryptosporidium gp60-Gen [Typ] in Probenmaterial mittels MolekulargenetikCryptosporidium gp60 gene, SpecimenCryptosporidium gp60 gène [Type] Milieux divers ; Résultat nominal ; Biologie moléculaireCryptosporidium gp60-gen [type] d.m.v. moleculair genetisch onderzoek
100870-5Cryptosporidium 18S rRNA [Genotyp] in Probenmaterial mittels MolekulargenetikCryptosporidium 18S genotype, SpecimenCryptosporidium 18S ARNr [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaireCryptosporidium 18S rRNA [genotype] d.m.v. moleculair genetisch onderzoek
100871-3Giardia lamblia gdh-Gen [Genotyp] in Probenmaterial mittels MolekulargenetikGiardia lamblia gdh gene genotype, SpecimenGiardia lamblia gdh gène [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaireGiardia lamblia gdh-gen [genotype] d.m.v. moleculair genetisch onderzoek
100872-1Bacteria producing polysaccharide from sucroseBactérie productrice de polysaccharide du saccharose [Présence/Seuil] Isolat ; QualitatifUit sucrose polysacharideproducerende bacterie [aanwezigheid] in isolaat
100873-9Giardia lamblia tpi-Gen [Genotyp] in Probenmaterial mittels MolekulargenetikGiardia lamblia tpi gene genotype, SpecimenGiardia lamblia tpi gène [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaireGiardia lamblia tpi-gen [genotype] d.m.v. moleculair genetisch onderzoek
100874-7Basidiobolus sp, SpecimenBasidiobolus [Présence/Seuil] Milieux divers ; QualitatifBasidiobolus sp. [aanwezigheid]
10087-5ST I-Amp 6ms L-IIIamplitud inicial del segmento ST, 6 mseg.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaST amplitud inicial 6 ms plomo III:Corazón :Punto temporal:Elpot:Cuantitativo:EKGST I-Amp 6ms L-III
100875-4Fet Hrt Doc Ltd US
100876-2Fet Hrt Doc US
100877-0US Heart Transesophageal during surgery
100878-8Endo US study Upr GI Tract Doc
100879-6US Guided Brst-R Cryoablation
100880-4US Guided Brst-L Cryoablation
100881-2MR Guided Bone Cryoablation
100882-0MR Peritoneum W contr percu
10088-3ST I-Amp 6ms L-V1amplitud inicial del segmento ST, 6 mseg.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaST amplitud inicial 6 ms cable V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKGDeprecated ST initial amp 6 ms.lead
100883-8MR Guided Kidney-L Bx
100884-6MR Guided Kidney-R Bx
100885-3Parapoxvirus , SpecimenParapoxvirus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cibleParapoxvirus DNA [aanwezigheid] d.m.v. probe-detectie
100886-1Orf virus, SpecimenOrf virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cibleOrfvirus DNA [aanwezigheid] d.m.v. probe-detectie
100887-9Pseudocowpox virus, SpecimenPseudocowpox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de ciblePseudokoepokvirus DNA [aanwezigheid] d.m.v. probe-detectie
100888-7Affenpocken-Virus Klade II DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionMonkeypox virus clade II, SpecimenMonkeypox de l'ouest africain virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible'Mpox'-virus clade II DNA [aanwezigheid] d.m.v. probe-detectie
100889-5Affenpocken-Virus Klade I DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit SondendetektionMonkeypox virus clade I, SpecimenMonkeypox Congo basin virus [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible'Mpox'-virus clade I DNA [aanwezigheid] d.m.v. probe-detectie
100890-3Poxvirus DNA panelPoxvirus ADN panel [-] Patient ; -Pokkenvirus DNA panel
10089-1ST I-Amp 6ms L-V2amplitud inicial del segmento ST, 6 mseg.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiogramaST amplitud inicial 6 ms. Derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKGST I-Amp 6ms L-V2
100891-1Orthopoxvirus IgG-Antikörper [Nachweis] in Serum oder Plasma mittels ImmunoassayOrthopoxvirus IgG antibody, BloodOrthopoxvirus Ac IgG [Présence/Seuil] Sérum/Plasma ; Qualitatif ; ImmunoanalyseOrthopoxvirus As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay
100892-9Orthopoxvirus IgM-Antikörper [Nachweis] in Serum oder Plasma mittels ImmunoassayOrthopoxvirus IgM antibody, BloodOrthopoxvirus Ac IgM [Présence/Seuil] Sérum/Plasma ; Qualitatif ; ImmunoanalyseOrthopoxvirus As.IgM [aanwezigheid] in serum of plasma d.m.v. immunoassay
100893-7Orthopoxvirus IgG & IgM Ab panel, BloodOrthopoxvirus IgG et IgM Ac panel [-] Sérum/Plasma ; -Orthopoxvirus IgG & IgM As panel in serum of plasma
100894-5Recommended screen freq
100895-2Rickettsia conorii IgG and IgM antibodies, BloodRickettsia conorii Ac IgG et IgM [Interprétation] Sérum ; Résultat nominalRickettsia conorii As.IgG & IgM [interpretatie] in serum
100896-0Vasopressin 13th specimen after challenge, BloodVasopressine T13 après épreuve [Moles/Volume] Plasma ; NumériqueVasopressine^13de monster na XXX belasting [mol/volume] in plasma
100897-8Staphylococcus aureus culture, SpecimenStaphylococcus aureus [Présence/Seuil] Milieux divers ; Qualitatif ; Culture spécifiqueStaphylococcus aureus [aanwezigheid] d.m.v. organisme-specifieke kweek
100898-6Lipid panel, BloodLipide panel [-] Sérum/Plasma ; -Lipiden panel in serum of plasma
100899-4Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype culture, SpecimenEnterobacteriaceae phénotype de résistance aux bêta lactamases à spectre élargi [Identification] Milieux divers ; Résultat nominal ; Culture spécifiqueEnterobacteriaceae.ESBL-resistentie fenotype [identificator] d.m.v. organisme-specifieke kweek

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

LvlA few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code